Webull has rescheduled $AIM's presentation in the @WebullGlobal Corporate Connect Virtual Webinar Series to Tuesday, November 17, at 2:40 p.m. ET.
Tune in for the latest company updates!
Register here: www.webull.com/webinar/detail/b8d9cde15fc74681a33c17a7483…
#oncology #immunotherapy
AIM ImmunoTech
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees. More on Wikipedia
-
AIM ImmunoTech
@AimImmuno
-
AIM ImmunoTech
@AimImmuno
At AIM ImmunoTech, we're focused on advancing immunotherapies to address serious unmet medical needs.
Through our lead program, we continue to explore new possibilities in oncology and immune-related diseases.
$AIM #immunotherapy #biotech -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Approaches Major Clinical Inflection Point with Phase 2 Pancreatic Cancer Data Expected Q1 2027; Reports Third Quarter 2026 Financial Results
aimimmuno.com/aim-immunotech-approaches-major-clinical-in…
$AIM #pancreaticcancer #oncology #cancerresearch -
AIM ImmunoTech
@AimImmuno
Starting soon! Tune in at 2:40 p.m. ET for $AIM’s presentation hosted by @WebullGlobal.
Join here: www.webull.com/webinar/detail/b8d9cde15fc74681a33c17a7483…
#oncology #immunotherapy -
AIM ImmunoTech
@AimImmuno
Join $AIM today at 2:40 p.m. ET for our presentation in the @WebullGlobal Corporate Connect Virtual Webinar Series.
Register here: www.webull.com/webinar/detail/b8d9cde15fc74681a33c17a7483…
#oncology #immunotherapy -
AIM ImmunoTech
@AimImmuno
Tune in tomorrow at 2:40 p.m. ET for $AIM’s presentation in the @WebullGlobal Corporate Connect Virtual Webinar Series.
Register here: www.webull.com/webinar/detail/b8d9cde15fc74681a33c17a7483…
#oncology #immunotherapy -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech to Present in the Webull Corporate Connect Webinar Series on Thursday, November 12, 2026 at 2:00 PM ET
aimimmuno.com/aim-immunotech-to-present-in-the-webull-cor…
$AIM #pancreaticcancer #oncology #cancerresearch -
AIM ImmunoTech
@AimImmuno
November is #pancreaticcancerawarenessmonth.
At $AIM, we remain committed to advancing research into innovative immunotherapies, including Ampligen and exploring new approaches for patients facing pancreatic cancer.
#pancreaticcancer #oncology -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Highlights Ampligen® Opportunity to Potentially Extend Benefits of RAS-Targeted Therapies in Pancreatic Cancer
aimimmuno.com/aim-immunotech-highlights-ampligen-opportun…
$AIM #pancreaticcancer #oncology #cancerresearch -
AIM ImmunoTech
@AimImmuno
Why wait for the next outbreak to prepare? AIM ImmunoTech CEO Tom Equels discusses broad-spectrum antiviral preparedness and Ampligen’s previously published Ebola research.
www.healthcarebusinesstoday.com/aim-immunotech-ceo-tom-eq… -
AIM ImmunoTech
@AimImmuno
Pancreatic cancer remains one of the most challenging cancers to treat, in part due to its highly immunosuppressive, or “cold,” tumor microenvironment.
At $AIM, we’re investigating how Ampligen may help reshape the tumor microenvironment and enhance anti-tumor immune responses. -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech has expanded European and U.K. patent protection for Ampligen in Long COVID and post-viral symptoms through 2041.
meditechtoday.com/aim-immunotechs-new-long-covid-patent-p… -
AIM ImmunoTech
@AimImmuno
What is a TLR3 agonist?
TLR3 plays a role in activating the body’s innate immune response. Ampligen is a highly selective TLR3 agonist and has the potential to reshape the tumor microenvironment and support an anti-tumor immune response.
$AIM #oncology #cancerresearch -
AIM ImmunoTech
@AimImmuno
Med World News looks at AIM ImmunoTech’s Phase 2 DURIPANC study and Ampligen’s potential role in addressing immune resistance in pancreatic cancer.
medworldnews.com/aim-immunotech-ampligen-pancreatic-cance… -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech’s Ampligen strategy takes aim at immune resistance in pancreatic cancer.
Read more in PharmaTech News: pharmatechnews.com/inside-aim-immunotechs-ampligen-strategy/ -
AIM ImmunoTech
@AimImmuno
Want to keep up with the latest from $AIM?
From clinical progress to corporate news and other important developments, get AIM ImmunoTech updates delivered directly to your inbox.
Sign up for email alerts: aimimmuno.com/email-alerts/
#oncology #cancerresearch -
AIM ImmunoTech
@AimImmuno
Check out the latest BioTuesdays article featuring $AIM and Ampligen, highlighting its potential across oncology, immune disorders and viral diseases, including ongoing research in pancreatic cancer.
Read more: biotuesdays.com/2026/10/06/aim-advancing-immunology-solut… -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech’s Strategy to Address Immune Resistance in Pancreatic Cancer Featured in BioTuesdays
aimimmuno.com/aim-immunotechs-strategy-to-address-immune-…
$AIM #pancreaticcancer #oncology #cancerresearch -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Highlights Recent Media Coverage of Ampligen’s® Broad-Spectrum Antiviral and Biodefense Potential
aimimmuno.com/aim-immunotech-highlights-recent-media-cove…
$AIM #pancreaticcancer #oncology #cancerresearch -
AIM ImmunoTech
@AimImmuno
This #breastcancerawarenessmonth, $AIM recognizes the patients, families, caregivers and advocates impacted by breast cancer.
We join the broader community in raising awareness and supporting continued progress in breast cancer research. -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Spotlights Growing Attention Around Ampligen Pancreatic Cancer Strategy as DURIPANC Advances Toward Topline Data
aimimmuno.com/aim-immunotech-spotlights-growing-attention…
$AIM #pancreaticcancer #oncology #cancerresearch -
AIM ImmunoTech
@AimImmuno
$AIM CEO Thomas K. Equels discusses how Ampligen® could complement emerging pancreatic cancer therapies, including supportive survival observations and upcoming Phase 2 DURIPANC milestones.
Watch the latest CEO Corner: vimeo.com/1231443780/367fab9785
#oncology #cancerresearch -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Discusses Ampligen®’s Potential to Complement Emerging Pancreatic Cancer Therapies in New CEO Corner Video
aimimmuno.com/aim-immunotech-discusses-ampligens-potentia…
$AIM #pancreaticcancer #oncology #cancerresearch -
AIM ImmunoTech
@AimImmuno
Stay connected to what’s next at AIM ImmunoTech.
Sign up for email alerts to receive the latest company news, clinical updates, press releases and other important developments directly to your inbox.
Stay informed: aimimmuno.com/email-alerts/
$AIM #oncology #cancerresearch -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Highlights Ampligen’s Potential Role in the Evolving Pancreatic Cancer Treatment Landscape Following FDA Approval of Revolution Medicines’ Daraxonrasib
aimimmuno.com/aim-immunotech-highlights-ampligens-potenti…
$AIM #pancreaticcancer #oncology #cancerresearch -
AIM ImmunoTech
@AimImmuno
#didyousee?
$AIM reached a key milestone ahead of schedule in the Phase 2 DURIPANC trial, with the final patient receiving their last dose of Ampligen®.
Primary endpoint analysis is anticipated to begin in December 2026.
Read more: aimimmuno.com/aim-immunotech-ahead-of-schedule-on-last-do…
#oncology -
AIM ImmunoTech
@AimImmuno
$AIM CEO Thomas K. Equels discusses Ampligen® and its continued advancement in pancreatic cancer, including the Phase 2 DURIPANC study and its potential to reshape the tumor microenvironment.
Watch the latest CEO Corner: vimeo.com/1225219727/91a420c432
#oncology #cancerresearch -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Highlights Scientific Rationale, Supportive Data and Continued Advancement of Ampligen® in Pancreatic Cancer in New CEO Corner Video
aimimmuno.com/aim-immunotech-highlights-scientific-ration…
$AIM #pancreaticcancer #oncology #cancerresearch -
AIM ImmunoTech
@AimImmuno
Today, on World Teal Day, we wear teal to raise awareness of ovarian cancer and stand with patients, survivors, families and loved ones impacted by this disease.
Together, we can help bring greater attention to ovarian cancer.
$AIM #worldtealday #ovariancancer -
AIM ImmunoTech
@AimImmuno
September is Ovarian Cancer Awareness Month.
Join us in raising awareness, supporting those impacted by ovarian cancer and recognizing the importance of continued research and education.
$AIM #ovariancancer #ovariancancerawarenessmonth #oncology #cancerresearch -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Significantly Expands Ampligen® Global Patent Estate with Long COVID Protection Across Europe and the United Kingdom Through 2041
aimimmuno.com/aim-immunotech-significantly-expands-amplig…
$AIM #longcovid -
AIM ImmunoTech
@AimImmuno
Behind every milestone is a team of experienced professionals.
AIM ImmunoTech is led by experts with extensive pharmaceutical development expertise, driving innovation across its programs.
Check out our management team: aimimmuno.com/management-team/
$AIM #cancerresearch -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Secures Broad U.S. Patent for Rintatolimod (Ampligen®) Used in Combination with Pembrolizumab (Keytruda®), Expanding Oncology IP Protection for Ampligen Through 2039
aimimmuno.com/aim-immunotech-secures-broad-u-s-patent-for…
$AIM #pancreaticcancer #oncology #cancerresearch -
AIM ImmunoTech reposted
Virtual Investor Co.
@InvestorVirtual
Every breakthrough begins with a reason to keep pushing forward.
Hear CEO Thomas Equels explain why advancing new approaches for pancreatic cancer patients matters now in the Virtual Investor Why Now Series.
Watch here: vimeo.com/1221551700/2b9974a30c
@AIMimmuno $AIM #pancreaticcancer #oncology #cancerresearch #virtualinvestor
@InvestorVirtual -
AIM ImmunoTech reposted
Virtual Investor Co.
@InvestorVirtual
Virtual Investor Launches "Why Now" On-Demand Conference Featuring Public Company CEOs
Nine CEOs. Nine investment stories. 60 seconds each to answer the question that matters most to investors: Why now?
Access the Conference Here: virtualinvestorco.com/why-now/
$AIM $AKTX $CNSP $DARE $NVNO $ERNA $GRI
$MBRX $OTLK @AimImmuno @AkariTX @cns_pharma @DareBioscience @enVVenoMedical @ErnexaTx @GRI_BIO @moleculinbio @OutlookTx -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Participates in the Virtual Investor ‘Why Now’ On-Demand Conference
Video now available here: virtualinvestorco.com/why-now/
aimimmuno.com/aim-immunotech-participates-in-the-virtual-…
$AIM #pancreaticcancer #oncology #cancerresearch #virtualinvestor @InvestorVirtual -
AIM ImmunoTech
@AimImmuno
Advancing therapeutic solutions starts with innovative science.
Ampligen® is AIM ImmunoTech's lead immuno-modulator, currently being evaluated in clinical studies for pancreatic cancer.
$AIM #oncologyresearch #immunology #cancerresearch -
AIM ImmunoTech
@AimImmuno
Advancing biodefense requires a proactive approach to identifying emerging threats and developing countermeasures that can help protect those who serve.
At $AIM, we recognize the importance of preparedness in supporting military force protection and readiness.
#oncology -
AIM ImmunoTech
@AimImmuno
$AIM ImmunoTech announced the publication of a new Breaking Defense article by CEO Thomas K. Equels highlighting biodefense, military force protection and the potential role of Ampligen® as a broad-spectrum antiviral countermeasure.
Read more: aimimmuno.com/aim-immunotech-ceo-highlights-biodefense-an… -
AIM ImmunoTech
@AimImmuno
The need for better pancreatic cancer treatments has never been greater.
Today, the overall 5-year survival rate remains just 13%, highlighting the importance of continued innovation in this disease.
$AIM #oncology #pancreaticcancer #cancerresearch -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech CEO Highlights Biodefense and Military Force Protection in Newly Published ‘Breaking Defense’ Article
aimimmuno.com/aim-immunotech-ceo-highlights-biodefense-an…
$AIM #pancreaticcancer #oncology #cancerresearch -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Reports Second Quarter 2026 Financial Results and Highlights Significant Operational Execution Advancing Ampligen® Toward Planned Phase 3 Development in Pancreatic Cancer
aimimmuno.com/aim-immunotech-reports-second-quarter-2026-…
$AIM #pancreaticcancer #oncology #cancerresearch -
AIM ImmunoTech
@AimImmuno
New coverage from @MedWorldNews highlights $AIMs ongoing work advancing Ampligen® in pancreatic cancer.
Read more about the Phase 2 DURIPANC trial and our efforts to address a significant unmet need: medworldnews.com/aim-immunotech-ampligen-pancreatic-cance…
#cancerresearch -
AIM ImmunoTech
@AimImmuno
Stay informed with AIM ImmunoTech.
Sign up to receive our latest press releases, SEC filings, investor updates and other company news delivered directly to your inbox.
Register here: aimimmuno.com/email-alerts/
$AIM #oncology #cancerresearch #immunology -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Ahead of Schedule on ‘Last Dose’ DURIPANC Critical Clinical Inflection Point
aimimmuno.com/aim-immunotech-ahead-of-schedule-on-last-do…
$AIM #pancreaticcancer #oncology #cancerresearch -
AIM ImmunoTech
@AimImmuno
In AIM ImmunoTech's latest CEO Corner, Thomas Equels shares their vision for advancing potential therapies while creating long-term value for patients and shareholders.
Learn more: vimeo.com/1207735025/5160e50f1e?fl=pl&fe=cm
$AIM #oncology #immunology #cancerresearch -
AIM ImmunoTech
@AimImmuno
Pharma Tech News recently spotlighted $AIM in an article by Spencer Hulse, highlighting the Company's Ampligen® strategy and its potential to address significant unmet needs in pancreatic cancer.
Read the full article: pharmatechnews.com/inside-aim-immunotechs-ampligen-strategy/
@PharmaTech_News -
AIM ImmunoTech
@AimImmuno
How could the DURIPANC study shape the future of Ampligen®?
In AIM ImmunoTech's latest CEO Corner, Thomas Equels discusses the study's clinical foundation and upcoming development milestones.
Watch the full discussion: vimeo.com/1207735025/5160e50f1e -
AIM ImmunoTech
@AimImmuno
Pancreatic cancer remains one of the deadliest cancers, highlighting the need for new treatment options.
Ampligen® has shown encouraging data across preclinical and clinical studies, supporting its potential in pancreatic cancer.
$AIM #pancreaticcancer #pancan #immunotherapy -
AIM ImmunoTech
@AimImmuno
In the latest CEO Corner, Thomas Equels highlights recent milestones across $AIMs pancreatic cancer program, including completed Phase 2 DURIPANC enrollment, encouraging clinical observations and continued progress.
Watch: vimeo.com/1207735025/5160e50f1e -
AIM ImmunoTech
@AimImmuno
Pancreatic cancer remains one of the most challenging cancers to treat.
In the latest CEO Corner, Thomas Equels discusses $AIMs mission and the potential of Ampligen® to address this significant unmet need.
Watch: vimeo.com/1207735025/5160e50f1e
#oncologyThis media couldn't be displayed. See it on the original post. -
AIM ImmunoTech
@AimImmuno
At $AIM ImmunoTech, we are focused on improving lives through the development of therapies with the potential to help patients across oncology, immune disorders and viral diseases.
#oncology #cancerresearch #pancreaticcancer #pancan -
AIM ImmunoTech
@AimImmuno
Never miss an AIM ImmunoTech update!
Subscribe to our email alerts for direct access to company announcements, clinical progress and corporate developments.
Sign Up Here: aimimmuno.com/email-alerts/
$AIM #oncology #cancerresearch #pancreaticcancer #pancan -
AIM ImmunoTech
@AimImmuno
Hear from our CEO.
Thomas Equels discusses the growing momentum behind our pancreatic cancer program, recent DURIPANC Phase 2 progress, upcoming clinical milestones and our commitment to advancing Ampligen® for patients with pancreatic cancer.
🔗: vimeo.com/1207735025/5160e50f1e?fl=tl&fe=ec -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Release of New CEO Corner Segment Highlighting Growing Momentum Across Pancreatic Cancer Program
aimimmuno.com/aim-immunotech-announces-release-of-new-ceo…
$AIM #pancreaticcancer #cancerresearch #oncology -
AIM ImmunoTech
@AimImmuno
This Fourth of July marks 250 years since the founding of the United States, a milestone that reflects generations of perseverance, possibility and progress.
Wishing everyone a meaningful Independence Day from all of us at AIM ImmunoTech.
#independenceday -
AIM ImmunoTech
@AimImmuno
#didyousee: $AIM announced a 50% ORR in a UPMC Phase 2 trial evaluating Ampligen with pembrolizumab and cisplatin in recurrent ovarian cancer, highlighting its potential to help overcome immune resistance and enhance checkpoint inhibitor activity.
🔗 aimimmuno.com/aim-immunotech-announces-50-objective-respo… -
AIM ImmunoTech
@AimImmuno
Want to stay up to date on our news, milestones and developments? Sign up for email alerts and receive updates directly.
aimimmuno.com/email-alerts/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
#startingnow!
We are live in the Corporate Connect Virtual Webinar Series hosted by @WebullGlobal at 2:40 PM ET.
Access registration here: www.webull.com/webinar/detail/7f0b59cd13104f5ab186f2fc068…
$AIM #cancerresearch #pancreaticcancer #breastcancer #ovariancancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
#tuneintoday!
Today we take the stage at 2:40pm ET during the Webull Corporate Connect Virtual Webinar Series.
Join $AIM to hear about our latest updates: www.webull.com/webinar/detail/7f0b59cd13104f5ab186f2fc068…
#cancerresearch @WebullGlobal -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Accelerates Toward Potential Pivotal Pancreatic Cancer Program as Ampligen Continues to Advance Through Key Clinical Milestones
aimimmuno.com/aim-immunotech-accelerates-toward-potential…
$AIM #pancreaticcancer #ovariancancer -
AIM ImmunoTech
@AimImmuno
#happeningtomorrow
We are participating in the Webull Corporate Connect Virtual Webinar Series tomorrow, June 24th at 2:40 PM ET.
Hear about what's next for us: www.webull.com/webinar/detail/7f0b59cd13104f5ab186f2fc068…
$AIM #cancerresearch @WebullGlobal -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech to Present in the Webull Corporate Connect Webinar Series on Wednesday, June 24th at 2:40 PM ET
aimimmuno.com/aim-immunotech-to-present-in-the-webull-cor…
$AIM #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Achieves Clinical Milestone as Final Subject Receives First Dose in Phase 2 DURIPANC Study in Metastatic Pancreatic Cancer
aimimmuno.com/aim-immunotech-achieves-clinical-milestone-…
$AIM #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Regains NYSE American Compliance, Company Resolves Stockholder Equity Deficiency
aimimmuno.com/aim-immunotech-regains-nyse-american-compli…
$AIM #ovariancancer #pancreaticcancer -
AIM ImmunoTech
@AimImmuno
#incaseyoumissedit: AIM ImmunoTech participated in a Virtual Investor KOL Connect featuring Professor Dr. Casper H.J. van Eijck and CEO Thomas Equels discussing Ampligen’s potential in late-stage pancreatic cancer.
Catch up here: vimeo.com/1192236396/29dc789f84?fl=ip&fe=ec
$AIM #pancreaticcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces $2.65 Million Financing Priced At-Market under NYSE American Rules
aimimmuno.com/aim-immunotech-announces-2-65-million-finan…
$AIM -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Reports Positive Mid-Year Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer
aimimmuno.com/aim-immunotech-reports-positive-mid-year-in…
$AIM #pancreaticcancer #pancan -
AIM ImmunoTech
@AimImmuno
June is #cancersurvivorsmonth.
Every story represents moments that once felt uncertain, milestones worth celebrating and the hope that continues to move progress forward.
At $AIM, we remain with the goal of helping create a future with more stories of hope ahead.
#oncology -
AIM ImmunoTech reposted
Virtual Investor Co.
@InvestorVirtual
In a #whatthismeans segment, Tom Equels, Dr. Charles Lapp and Dr. Christopher Nicodemus, examine current Ebola outbreak concerns, the unmet need surrounding the Bundibugyo strain, and Ampligen’s previously published antiviral research.
🔗: vimeo.com/1198375699/68d52d47b1?fl=tl&fe=ec
$AIM #ebola -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Releases Virtual Investor ‘What This Means’ Video Segment Discussing Ampligen’s Potential in Ebola Virus Disease Preparedness
aimimmuno.com/aim-immunotech-releases-virtual-investor-wh…
$AIM #virtualinvestor #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Completes Phase 2 DURIPANC Enrollment Milestone Ahead of Schedule, Advancing Ampligen Toward Critical Pancreatic Cancer Clinical Milestones
aimimmuno.com/aim-immunotech-completes-phase-2-duripanc-e…
$AIM #virtualinvestor #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Emerging Ebola Opportunity for Ampligen Amid Escalating Global Health Concerns and WHO Emergency Declaration
aimimmuno.com/aim-immunotech-announces-emerging-ebola-opp…
$AIM #cancerresearch #pancreaticcancer #breastcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces $2.4 Million Financing, Including Concurrent Registered Direct Offering and Private Placement
aimimmuno.com/aim-immunotech-announces-2-4-million-financ…
$AIM -
AIM ImmunoTech
@AimImmuno
An estimated 150K people lose their lives to late-stage pancreatic cancer each year.
In the latest Closing Bell segment, CEO Thomas Equels discusses how $AIM is working to address this significant unmet need.
Hear more: us02web.zoom.us/webinar/register/WN_ri5Z6o_tSbmgQxlsIGNPGg
#cancerresearch #oncology -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Significant Increase in Stockholder Equity and Extension of Promissory Note Maturity Date to June 2027, Enhancing Financial Flexibility and Supporting Strategic Clinical Priorities
aimimmuno.com/aim-immunotech-announces-significant-increa…
$AIM #cancerresearch #oncology -
AIM ImmunoTech
@AimImmuno
Stay up to date with the latest from $AIM.
Sign up for email alerts to receive company news and research updates directly to your inbox:
aimimmuno.com/email-alerts/
#cancerresearch #oncology -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Posts Virtual Investor Key Opinion Leader Segment Spotlighting Ampligen Breakthrough Data in Pancreatic Cancer
aimimmuno.com/aim-immunotech-posts-virtual-investor-key-o…
$AIM #cancerresearch #oncology -
AIM ImmunoTech
@AimImmuno
In our latest Closing Bell segment, CEO Thomas Equels highlighted our strategic focus on Ampligen, supported by promising clinical data and broad potential across key indications.
Watch here: us02web.zoom.us/webinar/register/WN_ri5Z6o_tSbmgQxlsIGNPGg
$AIM #cancerresearch #oncologyThis media couldn't be displayed. See it on the original post. -
AIM ImmunoTech
@AimImmuno
May is National Cancer Research Month, highlighting the progress shaping the future of oncology.
At $AIM, we are advancing an immune-based therapy to address critical unmet needs in cancer care.
#cancerresearch #oncology -
AIM ImmunoTech
@AimImmuno
Today on World Ovarian Cancer Day, we stand with the women impacted by this disease and honor those still battling.
Together, we AIM for more survivors. We AIM for a cure.
$AIM #worldovariancancerday #ovariancancerawareness #bettertreatments #brighterfutures #nowomanleftbehind -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech, Inc. Announces Exercise of Warrants for Approx. $4.2 Million in Gross Proceeds
aimimmuno.com/aim-immunotech-inc-announces-exercise-of-wa…
$AIM -
AIM ImmunoTech
@AimImmuno
On World Ovarian Cancer Day, we stand with patients and advocates working to raise awareness for a disease often diagnosed too late.
We remain committed to advancing research to improve outcomes.
$AIM #cancerresearch #oncology -
AIM ImmunoTech
@AimImmuno
$AIM CEO Tom Equels highlighted encouraging durability and clinical benefit observed with Ampligen, supporting its potential to enhance checkpoint immunotherapies across multiple solid tumor types, including ovarian and pancreatic cancer.
Learn more: aimimmuno.com/aim-immunotech-announces-50-objective-respo… -
AIM ImmunoTech
@AimImmuno
Dr. Edwards, highlighted encouraging improvements in clinical response rates and immune activation with the addition of IP Ampligen and PD-1 checkpoint inhibition to IP cisplatin chemotherapy across comparable ovarian cancer patient cohorts.
Learn more: aimimmuno.com/aim-immunotech-announces-50-objective-respo… -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces 50% Objective Response Rate (ORR) in UPMC Recurrent Ovarian Cancer Phase 2 Clinical Trial, Signaling Breakthrough Combination Potential
aimimmuno.com/aim-immunotech-announces-50-objective-respo…
$AIM #oncology #cancerresearch -
AIM ImmunoTech
@AimImmuno
As #cancercontrolmonth comes to a close, we recognize the patients, families, researchers and clinicians working every day to advance progress against #cancer.
To everyone fighting, supporting and driving progress forward, thank you.
$AIM #oncology #cancerresearch -
AIM ImmunoTech
@AimImmuno
Pancreatic cancer remains one of the deadliest cancers. In 2026, ~67,530 people in the U.S. will be diagnosed and ~52,740 will die.
With a lifetime risk of about 1 in 56 men and 1 in 60 women, awareness and research are critical.
$AIM #pancan #pancreaticcancer #cancerresearch -
AIM ImmunoTech
@AimImmuno
We received final approval of a Japanese patent covering the use of Ampligen in combination with checkpoint inhibitors for the treatment of cancer, further strengthening our intellectual property position and supporting our global development strategy.
🔗: aimimmuno.com/aim-immunotech-announces-final-approval-of-… -
AIM ImmunoTech
@AimImmuno
🔴 Starting Now!
We are live in the #virtualinvestor Closing Bell.
Tune in to hear from our CEO Tom Equels and participate in the live Q&A.
Join now: us02web.zoom.us/webinar/register/WN_ri5Z6o_tSbmgQxlsIGNPGg
$AIM #cancerresearch #pancreaticcancer #breastcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Enters Pivotal Value Inflection Phase with Planned Phase 3 Study of Ampligen® in Pancreatic Cancer, Backed by Positive Clinical Signals, Orphan Drug Status, and Global IP
aimimmuno.com/aim-immunotech-enters-pivotal-value-inflect…
$AIM #cancerresearch #pancreaticcancer #breastcancer -
AIM ImmunoTech
@AimImmuno
🔔 Happening Today!
We will be featured in the #virtualinvestor Closing Bell at 4 PM ET.
Don’t miss insights from our CEO Tom Equels, plus a live Q&A session.
Register here: us02web.zoom.us/webinar/register/WN_ri5Z6o_tSbmgQxlsIGNPGg
$AIM #cancerresearch #pancreaticcancer #breastcancer -
AIM ImmunoTech
@AimImmuno
#tuneintomorrow at 4 PM ET!
We will be participating in a #virtualinvestor Closing Bell.
Hear from our CEO Tom Equels and submit your questions live.
Secure your spot: us02web.zoom.us/webinar/register/WN_ri5Z6o_tSbmgQxlsIGNPGg
$AIM #cancerresearch #pancreaticcancer #breastcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Provides Routine Update on Annual Filings
aimimmuno.com/aim-immunotech-provides-routine-update-on-a…
$AIM -
AIM ImmunoTech
@AimImmuno
#markyourcalendars!
We will be joining a #virtualinvestor Closing Bell on Thursday, April 16 at 4 PM ET.
Our CEO Tom Equels will provide a corporate overview and business outlook, followed by a live Q&A.
Register here: us02web.zoom.us/webinar/register/WN_ri5Z6o_tSbmgQxlsIGNPGg
$AIM @investorvirtual -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech to Participate in Live Virtual Investor Closing Bell Event
aimimmuno.com/aim-immunotech-to-participate-in-live-virtu…
$AIM #cancerresearch #pancreaticcancer #breastcancer -
AIM ImmunoTech
@AimImmuno
Stay connected with the latest updates from AIM ImmunoTech.
Sign up for email alerts to receive news, research progress and company announcements straight to your inbox.
Subscribe today: aimimmuno.com/email-alerts/
$AIM #cancerresearch #oncology -
AIM ImmunoTech
@AimImmuno
April is #cancercontrolmonth, a time to recognize the patients and families impacted by cancer and the urgency behind the search for better treatments. At $AIM, we remain committed to advancing innovative research aimed at supporting those who need it most.
#cancerresearch -
AIM ImmunoTech
@AimImmuno
Get notified! Stay in the loop by signing up for email alerts and never miss an update!
aimimmuno.com/email-alerts/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
During #colorectalcancerawarenessmonth, we recognize that in 2026 the U.S. is expected to see ~159,000 new colon and rectal cancer cases and ~55,230 deaths.
These numbers reinforce the need for awareness, screening and action.
$AIM #colorectalcancer #cancerresearch -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Final Approval of Novel Cancer Therapy Patent in Japan Combining Ampligen with Checkpoint Inhibitors
aimimmuno.com/aim-immunotech-announces-final-approval-of-…
$AIM #cancerresearch #pancreaticcancer -
AIM ImmunoTech
@AimImmuno
Building momentum across multiple oncology programs where innovation is urgently needed.
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
March is National #colorectalcancerawarenessmonth.
This month, we stand with patients, families and caregivers to raise awareness and support progress in #oncology.
$AIM #colorectalcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Expiration and Preliminary Results of its Rights Offering for Aggregate Gross Proceeds of $1.8 Million
aimimmuno.com/aim-immunotech-announces-expiration-and-pre…
$AIM -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Signs Agreement for Planning of a Proposed Phase 3 Clinical Trial of Ampligen in the Treatment of Late-Stage Pancreatic Cancer
aimimmuno.com/aim-immunotech-signs-agreement-for-planning…
$AIM #cancerresearch #pancreaticcancer #breastcancer @thermofisher -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Reminds Stockholders of March 3, 2026 Expiration Date and Updates Terms of Previously Announced Rights Offering
aimimmuno.com/aim-immunotech-reminds-stockholders-of-marc…
$AIM -
AIM ImmunoTech
@AimImmuno
We are working to develop solutions that have the potential to help patients across a number of disease areas.
$AIMing to advance immunology solutions to create a better future.
#cancerresearch -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Extension of Subscription Period of its Previously Announced Rights Offering to March 3, 2026
aimimmuno.com/aim-immunotech-announces-extension-of-subsc…
$AIM -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Planned Milestones in the Ongoing Phase 2 Trial of Ampligen and AstraZeneca’s Durvalumab in the Treatment of Metastatic Pancreatic Cancer
aimimmuno.com/aim-immunotech-announces-planned-milestones…
$AIM #cancerresearch #pancreaticcancer #breastcancer -
AIM ImmunoTech
@AimImmuno
⏰ #startingsoon
$AIM will be live in the #virtualinvestor Closing Bell! Get the latest insights on clinical and regulatory strategy and ask questions during the live Q&A.
us02web.zoom.us/webinar/register/WN_bFyVvb-7RiaVtOqE3gWyTg
#cancerresearch #oncology #pancreaticcancer #pancan @investorvirtual -
AIM ImmunoTech
@AimImmuno
🔔 Going Live Today at 4 PM ET!
Get the latest corporate update, directly from our CEO Thomas Equels during a #virtualinvestor Closing Bell segment.
Don’t miss this opportunity!
Watch here: us02web.zoom.us/webinar/register/WN_bFyVvb-7RiaVtOqE3gWyTg
$AIM #oncology #pancreaticcancer #pancan @investorvirtual -
AIM ImmunoTech
@AimImmuno
Don't miss out! Stay in the loop by signing up for email alerts.
Register here: aimimmuno.com/email-alerts/
$AIM #cancerresearch #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
#didyouknow: #pancreaticcancer is the fourth leading cause of cancer-related deaths in the U.S.
Each year, around 60% of cases are diagnosed at an advanced stage, highlighting the importance of early detection and research.
$AIM #cancerresearch -
AIM ImmunoTech
@AimImmuno
CORRECTION: AIM ImmunoTech Announces Commencement of Rights Offering
aimimmuno.com/correction-aim-immunotech-announces-commenc…
$AIM #cancerresearch #pancreaticcancer #breastcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech to Participate in Live Virtual Investor Closing Bell Event on Thursday, February 19th at 4:00 PM ET.
aimimmuno.com/aim-immunotech-to-participate-in-live-virtu…
$AIM #cancerresearch #pancreaticcancer #breastcancer -
AIM ImmunoTech
@AimImmuno
#startingsoon!
Tune in at 1:40pm ET for our presentation in the Corporate Connect Virtual Webinar Series hosted by @WebullGlobal
Access registration here: www.webull.com/webinar/detail/870d23d4cc224e95a335e62e072…
$AIM #cancerresearch #pancreaticcancer #breastcancer #ovariancancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
#happeningtoday!
Today we take the stage at 1:40pm ET during the Webull Corporate Connect Virtual Webinar Series.
Join $AIM to hear about our latest updates: www.webull.com/webinar/detail/870d23d4cc224e95a335e62e072…
#cancerresearch @WebullGlobal -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Commencement of Rights Offering
aimimmuno.com/aim-immunotech-announces-commencement-of-ri…
$AIM -
AIM ImmunoTech
@AimImmuno
#tuneintomorrow
We will be participating in the Webull Corporate Connect Virtual Webinar Series tomorrow, February 11th at 1:40pm ET.
Explore what's next for us: www.webull.com/webinar/detail/870d23d4cc224e95a335e62e072…
$AIM #cancerresearch @WebullGlobal -
AIM ImmunoTech
@AimImmuno
This #nationalcancerpreventionmonth, AIM ImmunoTech highlights the importance of innovation in cancer prevention and treatment by advancing immune-based research to address critical unmet needs.
$AIM #cancerresearch -
AIM ImmunoTech
@AimImmuno
#markyourcalendars
$AIM will be presenting in the Corporate Connect Virtual Webinar Series hosted by @WebullGlobal on Wednesday, February 11th at 1:40pm ET!
Register Here: www.webull.com/webinar/detail/870d23d4cc224e95a335e62e072…
#cancerresearch -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial on Wednesday, February 11th at 1:40 PM EST
aimimmuno.com/aim-immunotech-to-participate-in-the-corpor…
$AIM #cancerresearch #pancreaticcancer #breastcancer -
AIM ImmunoTech
@AimImmuno
Our CEO, Thomas Equels, highlighted the urgent need for better treatments in metastatic pancreatic cancer and the potential for Ampligen to meaningfully improve both survival and quality of life for patients facing this devastating disease.
Learn more: aimimmuno.com/aim-immunotech-reports-positive-year-end-in… -
AIM ImmunoTech
@AimImmuno
$AIM ImmunoTech Reports Positive Year-End Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer
aimimmuno.com/aim-immunotech-reports-positive-year-end-in…
#cancerresearch -
AIM ImmunoTech
@AimImmuno
This #worldcancerday, we stand with patients and researchers worldwide.
We $AIM to find new solutions in cancer care.
#cancerresearch #pancreaticcancer #breastcancer -
AIM ImmunoTech
@AimImmuno
Sign up for our email alerts to have the latest news and information delivered directly to your inbox!
aimimmuno.com/email-alerts/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Changes to Key Dates and Terms Related to Announced Rights Offering
aimimmuno.com/aim-immunotech-announces-changes-to-key-dat…
$AIM -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Key Dates and Terms Related to Announced Rights Offering
aimimmuno.com/aim-immunotech-announces-key-dates-and-term…
$AIM -
AIM ImmunoTech
@AimImmuno
Our lead program is an immuno-modulator that has shown significant positive data published in numerous well-respected journals and forums.
Learn more: aimimmuno.com/scientific-publications/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
CEO Tom Equels recently participated in a CEO Corner segment highlighting the unmet need in pancreatic cancer, along with #aim’s lead program and its ongoing evaluation in the DURIPANC Phase 1b/2 clinical trial in combination with AstraZeneca’s Imfinzi®.
vimeo.com/1145051019/6fbecd199f?share=copy&fl=sv&fe=ci -
AIM ImmunoTech
@AimImmuno
In 2026, #aim ImmunoTech continues to advance its mission to improve lives by developing therapies to treat multiple types of cancers, immune disorders, and viral diseases.
#pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Wishing you a happy and healthy New Year from all of us at AIM!
#happynewyear -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Stock Dividend
aimimmuno.com/aim-immunotech-announces-stock-dividend/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
Happy Holidays from our AIM family to yours. Wishing you a season filled with health, hope and peace.
#happyholidays -
AIM ImmunoTech
@AimImmuno
Get notified! Stay in the loop by signing up for email alerts and never miss an update!
aimimmuno.com/email-alerts/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
#pancreaticcancer is the fourth leading cause of cancer-related deaths in the U.S. Each year, around 60% of cases are diagnosed at an advanced stage, highlighting the importance of early detection and research.
$AIM -
AIM ImmunoTech
@AimImmuno
Our pipeline continues to advance as we move forward with multiple active and planned studies, with pancreatic cancer as our lead indication.
Explore our latest pipeline to see what is ahead: aimimmuno.com/pipeline/
$AIM #pancan #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
aimimmuno.com/aim-immunotech-announces-release-of-the-nex…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
At $AIM, our mission is personal. We’re driven by the patients, families and communities affected by cancer and chronic illness, and by the hope for better options.
#cancerresearch #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
🔔 Going Live Today at 4 PM ET!
Get the latest insights on #aim directly from CEO Thomas Equels during a #virtualinvestor Closing Bell segment. Don’t miss this opportunity!
Watch here: us02web.zoom.us/webinar/register/WN_R51sg35FSh-M6waNMf14dA
#cancerresearch #pancreaticcancer #pancan @investorvirtual -
AIM ImmunoTech
@AimImmuno
#tuneintomorrow at 4 PM ET!
$AIM CEO Thomas Equels live in a #virtualinvestor Closing Bell segment.
Don’t miss out: us02web.zoom.us/webinar/register/WN_R51sg35FSh-M6waNMf14dA
#cancerresearch #pancreaticcancer #pancan @investorvirtual -
AIM ImmunoTech
@AimImmuno
#savethedate!
CEO Thomas Equels will participate in a #virtualinvestor Closing Bell segment on December 4th at 4 PM ET.
Don’t miss this live corporate update and interactive Q&A.
🔗 Access the event: us02web.zoom.us/webinar/register/WN_R51sg35FSh-M6waNMf14dA
$AIM #cancerresearch #pancreaticcancer #pancan -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech to Participate in Live ‘Fireside’ Chat on Virtual Investor Closing Bell Series on Thursday, December 4th at 4:00 PM ET
aimimmuno.com/aim-immunotech-to-participate-in-live-fires…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
Today is World Pancreatic Cancer Day!
Together, we can raise awareness, support those affected and advocate for better care and earlier detection.
Learn more: www.aacr.org/patients-caregivers/awareness-months/pancrea…
$AIM #worldpancreaticcancerday #pcam -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Reports Third Quarter 2025 Financial Results and Highlights Continued Progress Across Pipeline with Strategic Focus on Pancreatic Cancer Clinical Program
aimimmuno.com/aim-immunotech-reports-third-quarter-2025-f…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
Discover the latest on our active and planned studies as we continue advancing toward key data milestones. Every step brings us closer to new possibilities in immune-based therapies.
aimimmuno.com/pipeline/
$AIM #cancerresearch -
AIM ImmunoTech
@AimImmuno
More than 60,000 people in the U.S. are diagnosed with pancreatic cancer each year. Behind every statistic is a story of strength, resilience, and hope. At $AIM, we stand with patients, families and caregivers in the fight to change these outcomes.
#pcam -
AIM ImmunoTech
@AimImmuno
We’re harnessing the power of the immune system to fight cancer.
Our technology is designed to reprogram immune responses and strengthen the body’s natural defenses, driving innovation in immunotherapy.
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Details New UPMC Abstract on Completed Clinical Trial Involving Ampligen’s Synergistic Potential in the Treatment of Advanced Recurrent Ovarian Cancer
aimimmuno.com/aim-immunotech-details-new-upmc-abstract-on…
$AIM #pancsm #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
November is #pancreaticcancerawarenessmonth
At AIM ImmunoTech, we stand with everyone affected by this devastating disease and remain committed to advancing research and awareness.
Learn more: www.aacr.org/patients-caregivers/awareness-months/pancrea…
$AIM #pancreaticcancer #pcam -
AIM ImmunoTech
@AimImmuno
Pancreatic cancer remains one of the deadliest cancers in the U.S., ranking 4th in cancer-related deaths.
With nearly 60% of cases found at advanced stages, we must push for earlier detection and continued research.
$AIM #pancreaticcancer #aimimmunotech -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Late Breaking Abstract from University of Pittsburgh Medical Center Accepted for Presentation at the 40th Annual Society for Immunotherapy of Cancer (SITC) Meeting
aimimmuno.com/aim-immunotech-announces-late-breaking-abst…
$AIM #pancsm #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces European Patent Office Grants Patent Covering Ampligen® (Rintatolimod) for Use in the Treatment of the Post-COVID Condition of Fatigue
aimimmuno.com/aim-immunotech-announces-european-patent-of…
$AIM #covid #longcovid #postcovid -
AIM ImmunoTech
@AimImmuno
At $AIM, our goal is simple: bring better options to patients battling cancer and chronic illness.
Every step we take is driven by hope, science and the lives we aim to impact.
#pancreaticcancer #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
Our lead program has generated a growing body of positive data highlighted in respected journals and forums. Explore our publications: aimimmuno.com/scientific-publications/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
In 2025, an estimated 67,440 Americans will be diagnosed with pancreatic cancer and ~51,980 will lose their lives.
At AIM Immunotech, we are committed to bringing hope to patients and breaking barriers.
$AIM #pancreaticcancer #aimimmunotech -
AIM ImmunoTech
@AimImmuno
$AIM is excited to attend the Maxim Growth Summit in New York, October 22–23, 2025.
We look forward to engaging with the investment community!
#pancreaticcancer #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech to Attend the 2025 Maxim Growth Summit
aimimmuno.com/aim-immunotech-to-attend-the-2025-maxim-gro…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcance -
AIM ImmunoTech
@AimImmuno
New research from @OxBioDynamics demonstrates progress toward identifying a biomarker for ME/CFS - an important step in validating this complex and often misunderstood condition as a real, biological disease. $AIM remains committed to advancing research.
idp.springer.com/transit?redirect_uri=https%3A%2F%2Flink.… -
AIM ImmunoTech
@AimImmuno
Each year in the U.S., over 287,000 people are diagnosed with breast cancer and over 43,000 lives are lost. AIM ImmunoTech stands with patients and families as we work to drive progress and raise awareness.
$AIM #breastcancerawareness #bcam #aimimmunotech -
AIM ImmunoTech
@AimImmuno
As Ovarian Cancer Awareness Month comes to a close, we remember those affected by this disease and stand with patients, survivors, and their families. Let's continue to raise awareness and make a difference. 💙
Learn more here: www.aacr.org/patients-caregivers/awareness-months/ovarian…
$AIM @AACR -
AIM ImmunoTech
@AimImmuno
Be the First to Know
Get the latest news, updates and insights delivered straight to your inbox — before anyone else.
Don’t miss out! Sign up here: aimimmuno.com/email-alerts/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Secures Patent in Japan Through 2039 for Novel Cancer Therapy Combining Ampligen® (Rintatolimod) with Checkpoint Inhibitors
aimimmuno.com/aim-immunotech-secures-patent-in-japan-thro…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Publication of Journal Article On the Positive Effect of Ampligen and Interferon-Alpha on Tumor Growth
aimimmuno.com/aim-immunotech-announces-publication-of-jou…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
We announced positive data in our mid-year update from our ongoing Phase 2 DURIPANC study. The trial is evaluating Ampligen® in combination with @AstraZeneca’s Imfinzi® for the treatment of metastatic #pancreaticcancer patients.
See the details: aimimmuno.com/aim-immunotech-reports-positive-mid-year-sa…
$AIM -
AIM ImmunoTech
@AimImmuno
#pancreaticcancer is the fourth leading cause of cancer-related deaths in the U.S. Each year, around 60% of cases are diagnosed at an advanced stage, highlighting the importance of early detection and research.
$AIM -
AIM ImmunoTech
@AimImmuno
In Case You Missed It: $AIM recently presented at the LIVE! Biotech & Medtech Investment Webinar Week, hosted by Webull Corporate Connect.
Catch up on our presentation and hear what’s next for AIM here: www.webull.com/learn/courseware/JPqP7g/Corporate-Connect-…
@WebullGlobal -
AIM ImmunoTech
@AimImmuno
62,210 new cases each year - #pancreaticcancer remains one of the most challenging cancers, and it is a key focus for Ampligen, driven by the urgent need for better treatments. We're dedicated to making a real difference.
aimimmuno.com/immuno-oncology-2/
$AIM #panccancer -
AIM ImmunoTech
@AimImmuno
September is Ovarian Cancer Awareness Month 💙
Join us as we raise awareness about this serious disease and share ways you can make a difference.
Learn more and get involved here: www.aacr.org/patients-caregivers/awareness-months/ovarian…
$AIM @AACR #ovariancancer #ovariancancerawarenessmonth -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Highlights Growing Body of Compelling Data of Ampligen for the Treatment of Pancreatic Cancer at Conference in Poland
aimimmuno.com/aim-immunotech-highlights-growing-body-of-c…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
We’ll be attending the 5th Annual Maria Sklodowska–Curie Symposium on Cancer Research and Care, September 3–5 in Warsaw, Poland.
Together, we’re advancing cancer research through shared knowledge and common goals.
Looking forward to meaningful conversations and collaborations! -
AIM ImmunoTech
@AimImmuno
We’re open to collaboration—including out-licensing, co-research, co-development, co-promotion and co-marketing—with pharma, biotech, and research institutes worldwide.
Interested? Contact us at info@AIMimmuno.com.
$AIM -
AIM ImmunoTech
@AimImmuno
CEO of $AIM, Thomas Equels, shared a “state of the union” corporate update and discussed recent scientific progress with lead product candidate, Ampligen.
Access their CEO Corner segment to learn more: vimeo.com/1111956348/23d8efc360 -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
aimimmuno.com/aim-immunotech-announces-release-of-the-nex…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
Coming up! $AIM is set to present at Webull’s LIVE! Biotech & Medtech Investment Webinar Week.
📅 Today, August 20th @ 2:40 PM ET
🔗 Reserve your spot: www.webull.com/webinar
@WebullGlobal -
AIM ImmunoTech
@AimImmuno
Join $AIM at the LIVE! Biotech & Medtech Investment Webinar Week, hosted by Webull Corporate Connect, happening August 20th at 2:40pm ET.
We’re sharing what’s next — and why now is the time to pay attention.
Reserve your spot: www.webull.com/webinar
@WebullGlobal -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Reports Second Quarter 2025 Financial Results and Provides Corporate Update
aimimmuno.com/aim-immunotech-reports-second-quarter-2025-…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
#dontmissit — $AIM is joining the LIVE! Biotech & Medtech Investment Webinar Week August 20th at 2:40 PM ET, hosted by Webull Corporate Connect.
Hear more about the company’s mission and momentum.
Register now: www.webull.com/webinar
@WebullGlobal -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
aimimmuno.com/aim-immunotech-to-present-at-the-webull-fin…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
$AIM recently announced encouraging preliminary Phase 2 data for Ampligen® in combination with AstraZeneca’s Imfinzi® for #pancreaticcancer.
Early results show no significant toxicity and promising signs of improved progression-free and overall survival
aimimmuno.com/aim-immunotech-reports-positive-mid-year-sa… -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech’s Oncology Drug Ampligen to Be Featured in Key Presentations and Abstract at the International 5th Annual Marie Skłodowska-Curie Symposium on Cancer Research and Care (MSCI MSCS-2025)
aimimmuno.com/aim-immunotechs-oncology-drug-ampligen-to-b…
$AIM #pancsm #ovaca #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Builds Positive Momentum and Reiterates Focus on Driving Ampligen® Clinical Development Toward Pancreatic Cancer Approval
aimimmuno.com/aim-immunotech-builds-positive-momentum-and…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Closing of $8.0 Million Public Offering
aimimmuno.com/aim-immunotech-announces-closing-of-8-0-mil…
$AIM -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Pricing of $8.0 Million Public Offering
aimimmuno.com/aim-immunotech-announces-pricing-of-8-0-mil…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Reports Positive Mid-year Safety and Efficacy Data from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer
aimimmuno.com/aim-immunotech-reports-positive-mid-year-sa…
$AIM -
AIM ImmunoTech
@AimImmuno
Targeting multiple cancers with high-unmet need.
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
Don’t miss an update — sign up for email alerts to stay updated on our latest news, breakthroughs and clinical progress.
📩 aimimmuno.com/email-alerts/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #mecfs -
AIM ImmunoTech
@AimImmuno
Our lead program has the potential to induce a wide range of immunologic / antitumor activities.
Learn more here: aimimmuno.com/ampligen/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #mecfs -
AIM ImmunoTech
@AimImmuno
The recent securing of a key U.S. patent is a significant milestone for AIM, marking the final step in a multi-year project to strengthen and secure our global patent portfolio surrounding Ampligen®
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #mecfs -
AIM ImmunoTech
@AimImmuno
Happy Independence Day from all of us! Wishing you a safe and celebratory 4th of July.
-
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Recent Presentation on the Potential of Private-Public Partnerships for the Development of Oncology Therapies
aimimmuno.com/aim-immunotech-announces-recent-presentatio…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
#incaseyoumissedit: We were recently granted a U.S. patent covering methods of manufacturing therapeutic dsRNA, including Ampligen® — a key advancement in our growing IP portfolio.
Take a look here: aimimmuno.com/aim-immunotech-granted-u-s-patent-covering-…
$AIM -
AIM ImmunoTech
@AimImmuno
Get notified! Stay in the loop by signing up for email alerts and never miss an update!
aimimmuno.com/email-alerts/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
At the #aai25 Annual Meeting, Dr. Pawel Kalinski presented new data highlighting Ampligen’s unique dual selectivity in modulating the tumor microenvironment — promoting CTL influx without triggering counterproductive immune responses.
aimimmuno.com/aim-immunotech-announces-the-presentation-o…
@ImmunologyAAI -
AIM ImmunoTech
@AimImmuno
📢 Ampligen Pipeline Update
Explore the current status of our active and planned studies as we advance efforts to drive toward key data.
aimimmuno.com/pipeline/
#aim #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
At $AIM, we’re driven by the lives we aim to impact — patients facing cancer diagnoses, those living with chronic illness and families hoping for better options.
Our mission is deeply personal: to push the boundaries of science so that no one has to face these battles alone. -
AIM ImmunoTech
@AimImmuno
As concerns grow over the spread of Highly Pathogenic Avian Influenza, innovative treatments are crucial. Our CEO, Thomas Equels, explains how Ampligen could offer a powerful new defense against bird flu.
Watch here: vimeo.com/1055266036
$AIM #birdflu #flu -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Resumes Trading on NYSE American
aimimmuno.com/aim-immunotech-resumes-trading-on-nyse-amer…
$AIM $AIMI -
AIM ImmunoTech
@AimImmuno
This #menshealthweek, we reflect on the fathers, brothers, sons and partners who’ve faced cancer with quiet strength and unwavering courage.
$AIMI $AIM #pancreaticcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Granted U.S. Patent Covering Methods of Manufacturing Therapeutic dsRNA, Including Ampligen®
aimimmuno.com/aim-immunotech-granted-u-s-patent-covering-…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces NYSE American Removal of Trading Suspension
aimimmuno.com/aim-immunotech-announces-nyse-american-remo…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces 1-for-100 Reverse Stock Split
aimimmuno.com/aim-immunotech-announces-1-for-100-reverse-…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Don't miss an important notification! Stay up-to-date with $AIMI by signing up for email alerts here: aimimmuno.com/email-alerts/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
#icymi: Our #whatthismeans segment with CEO Tom Equels and Professor van Eijck discussed the approval from the Erasmus MC Safety Committee to proceed with the Phase 2 study of Ampligen in combination with AstraZeneca’s Imfinzi for late-stage #panccancer
vimeo.com/1055266036/b14afc3559 -
AIM ImmunoTech
@AimImmuno
Our pipeline continues to drive toward data. Review our most recent pipeline update for the current status of active and planned studies.
aimimmuno.com/pipeline/
$AIMI $AIM #oncology #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
#didyouknow: ME/CFS is a disease characterized by profound fatigue, sleep abnormalities and pain. ME/CFS occurs more commonly in women and the cause of the condition is unknown.
Get a better understanding here: www.cdc.gov/me-cfs/about/index.html
$AIMI $AIM #mecfs #chronicfatigue -
AIM ImmunoTech
@AimImmuno
Our lead program is being developed with the potential for broad applicability across multiple indications, offering an innovative approach to addressing diverse patient needs.
$AIMI $AIM #oncology #panccancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
May 12th is #mecfsawarenessday — a day to recognize those affected by Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and the urgent need for increased research, awareness and support.
Take action here: www.cdc.gov/me-cfs/resources/awarenessday.html
$AIMI $AIM #mecfs #chronicfatigue -
AIM ImmunoTech
@AimImmuno
Today marks #worldovariancancerday, a global call to raise awareness, spark conversations, and drive action against ovarian cancer.
🔗 Learn more: worldovariancancercoalition.org/world-ovarian-cancer-day/
$AIMI $AIM #oncology #ovariancancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces the Presentation of Ampligen Oncology Data at the Recent Annual Meeting of the American Association of Immunologists
aimimmuno.com/aim-immunotech-announces-the-presentation-o…
$AIM $AIMI #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
We are an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases. aimimmuno.com/about/
$AIMI $AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
As #cancercontrolmonth comes to a close, we reflect on the strength, courage and resilience of those impacted by cancer. The fight continues, and together, we remain committed to advancing research, improving treatments and supporting those who need it most.
$AIMI #aim #oncology -
AIM ImmunoTech
@AimImmuno
#didyousee: Our very own Dr. Roane co-authored "The Story Behind the Science: On the Discovery of Respiratory Syncytial Virus," exploring the landmark discovery of RSV and its impact on our understanding of the virus.
Read it here: journals.asm.org/doi/10.1128/mbio.03074-24
$AIMI #aim #rsv -
AIM ImmunoTech
@AimImmuno
Our lead program is unique in its mechanism of action. Learn more: aimimmuno.com/ampligen/
$AIMI #aim #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
Our CEO, Tom Equels highlights the potential of combining Ampligen and FluMist as a rapid, cost-effective solution for avian influenza.
Learn more here: aimimmuno.com/aim-announces-paul-goepfert-md-as-the-princ…
$AIMI #aim #birdflu #flu -
AIM ImmunoTech
@AimImmuno
During #cancercontrolmonth, we honor the strength of those who have battled and are battling cancer, and the families who support them.
$AIMI #aim #oncology #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
$AIMI CEO, Thomas Equels, shared his top five reasons why he believes the investment community and industry leaders should pay attention to the Company in 2025. Listen to his insights here: vimeo.com/1064668442/51546fe36e
#aim #panccancer #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
We're excited to share "The Story Behind the Science: On the Discovery of Respiratory Syncytial Virus," co-authored by Dr. Roane, a distinguished member of our Scientific Advisory Board, recently published in The American Society for Microbiology.
journals.asm.org/doi/10.1128/mbio.03074-24
#aimi -
AIM ImmunoTech
@AimImmuno
April is #cancercontrolmonth, a time to honor those impacted by cancer and highlight the urgent need for improved treatments. Every day, individuals and families face challenges related to #cancer —together, we can pave the way for brighter futures.
$AIMI #aim #oncology -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Trading Under the Ticker $AIMI on the Pink Open Market
aimimmuno.com/aim-immunotech-announces-trading-under-the-…
$AIM -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces NYSE American Notice of Delisting and Appeal
aimimmuno.com/aim-immunotech-announces-nyse-american-noti…
$AIM -
AIM ImmunoTech
@AimImmuno
As #colorectalcancerawarenessmonth comes to a close, our fight against colorectal cancer continues. Every effort counts in making a difference.
Learn more//bit.ly/42MuudW
$AIM #oncology -
AIM ImmunoTech
@AimImmuno
Get notified! Stay in the loop by signing up for email alerts and never miss an update!
aimimmuno.com/email-alerts/
#aim #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
During #colorectalcancerawarenessmonth, we acknowledge the approximately 150,000 new cases and 52,000 lives lost each year. It highlights the urgent need for awareness, support, and action. Join the fight!
socialpresskit.com/colorectal-cancer-alliance
$AIM #oncology -
AIM ImmunoTech reposted
Virtual Investor Co.
@InvestorVirtual
AIM ImmunoTech in the spotlight! Catch @aimimmuno participation in the #virtualinvestor On-Demand Conference now: vimeo.com/1064668442/51546fe36e
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Inc. Participates in the Virtual Investor “Top 5 for ’25” On-Demand Conference
aimimmuno.com/aim-immunotech-inc-participates-in-the-virt…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
Ampligen has been shown to reprogram the immune system and enhance the cellular response, strengthening the body's natural defenses in the fight against cancer.
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
Targeting multiple cancers with high-unmet need.
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
March is National #colorectalcancerawarenessmonth. This month, we stand together to raise awareness and support those affected by #colorectalcancer.
Discover how you can make an impact here: socialpresskit.com/colorectal-cancer-alliance
$AIM #oncology -
AIM ImmunoTech
@AimImmuno
AIM announces Paul Goepfert, MD, as the principal investigator for the planned clinical study of Ampligen and FluMist as a vaccine for bird flu
aimimmuno.com/aim-announces-paul-goepfert-md-as-the-princ…
$AIM #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer #avianinfluenza #birdflu -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces NYSE American Acceptance of Plan to Regain Listing Compliance
aimimmuno.com/aim-immunotech-announces-nyse-american-acce…
$AIM #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Appoints David Chemerow to Board of Directors as an Independent Director
aimimmuno.com/aim-immunotech-appoints-david-chemerow-to-b…
$AIM #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
AIM Doses First New Subject in Phase 2 Study of Ampligen and Imfinzi as a Potential Combination Therapy for Late-Stage Pancreatic Cancer
aimimmuno.com/aim-doses-first-new-subject-in-phase-2-stud…
$AIM #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
Our lead program has shown clinical potential and encouraging results! Learn more: aimimmuno.com/ampligen/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Sign up for our email alerts to have the latest news and information delivered directly to your inbox!
aimimmuno.com/email-alerts/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Our lead program is an immuno-modulator that has shown positive data published in
numerous well-respected journals and forums. Learn more: aimimmuno.com/scientific-publications/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
#longcovid is a condition where individuals have prolonged symptoms for weeks, months, or even years beyond the initial infection. Symptoms can include brain fog, fatigue, sleep disorders and joint pain. Find out more here: www.cdc.gov/covid/long-term-effects/long-covid-signs-symp…
$AIM #longcovid -
AIM ImmunoTech reposted
Virtual Investor Co.
@InvestorVirtual
#whatthismeans – Thomas Equels and Professor van Eijck discuss the recent approval of Erasmus MC Safety Committee to proceed with the Phase 2 Study of Ampligen and AstraZeneca’s Imfinzi for late-stage #pancreaticcancer.
vimeo.com/1055266036/b14afc3559 $AIM -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Releases Virtual Investor “What This Means Segment”
aimimmuno.com/aim-immunotech-releases-virtual-investor-wh…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech announces that it will not proceed with an offering pursuant to its Registration Statement on Form S-1 until after it files its Annual Report on Form 10-K for the fiscal year ended December 31, 2024
aimimmuno.com/aim-immunotech-announces-that-it-will-not-p…
$AIM #cancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
We are working to develop solutions that have the potential to help patients across a number of disease areas. Our $AIM is to advance immunology solutions to create a better future.
#pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Our CEO, Tom Equels, discusses the importance of addressing the recent avian influenza outbreaks with potential treatments such as the Company’s proposed combination treatment of $AIM’s Ampligen® and AstraZeneca’s FluMist®
aimimmuno.com/aim-immunotech-announces-a-planned-follow-u…
#avianflu #influenza #birdflu -
AIM ImmunoTech
@AimImmuno
February marks #nationalcancerpreventionmonth, a time to raise awareness about the steps we can take to reduce the risk of cancer and protect our health. Explore practical tips and valuable resources to make prevention a priority: www.aacr.org/patients-caregivers/awareness-months/nationa…
$AIM -
AIM ImmunoTech
@AimImmuno
$AIM ImmunoTech announces a planned follow-up clinical study evaluating a combination treatment of AIM’s Ampligen® and AstraZeneca’s FluMist® to address the recent avian influenza outbreaks
aimimmuno.com/aim-immunotech-announces-a-planned-follow-u… -
AIM ImmunoTech
@AimImmuno
Erasmus Medical Center Safety Committee Grants Approval to Proceed with Phase 2 Study of Ampligen® and Imfinzi as a Potential Combination Therapy for Late-Stage Pancreatic Cancer
aimimmuno.com/erasmus-medical-center-safety-committee-gra…
$AIM #pancreaticcancer -
AIM ImmunoTech
@AimImmuno
62,210 new cases each year. #pancreaticcancer remains one of the most challenging cancers, and it is a key focus for Ampligen, driven by the urgent need for better treatments. We're dedicated to making a real difference.
aimimmuno.com/immuno-oncology-2/
$AIM #panccancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Publication of Final Clinical Study Results for AMP-518 Clinical Trial on Ampligen as a Therapeutic for Post-COVID Conditions
aimimmuno.com/aim-immunotech-announces-publication-of-fin…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Highlights New Article Finding Links Between COVID-19 and ME/CFS
aimimmuno.com/aim-immunotech-highlights-new-article-findi…
$AIM #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
#longcovid affects nearly 1 in 5 Americans, with lingering symptoms long after the initial infection. At $AIM, we are committed to exploring potential treatments that can offer relief to those suffering from this debilitating condition.
Learn more//bit.ly/3ZmJ9uO -
AIM ImmunoTech
@AimImmuno
We believe in the power of Ampligen to work in conjunction with a variety of chemotherapy regimens and/or immune checkpoint inhibitors.
$AIM #breastcancer -
AIM ImmunoTech
@AimImmuno
#incaseyoumissedit: Data from Roswell Park Comprehensive Cancer Center's Phase 1 study of our lead program in early-stage triple-negative breast cancer was published in The Journal for Immunotherapy of Cancer.
Find out more here: www.roswellpark.org/newsroom/202411-roswell-park-clinical…
$AIM #breastcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Highlights Key 2024 Achievements and Outlines Upcoming 2025-26 Value-Driving Milestones
aimimmuno.com/aim-immunotech-highlights-key-2024-achievem…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
We are seeking collaborative opportunities in various areas. If you're interested in partnering, please contact us at info@AIMimmuno.com.
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
We are working to reprogram the tumor microenvironment to convert “cold” tumors into “hot” tumors that will be responsive to checkpoint blockage.
Find out more here: aimimmuno.com/ampligen/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
In 2025, our #aim to improve lives is stronger than ever.
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Wishing you and your family a Happy New Year!
-
AIM ImmunoTech
@AimImmuno
#happyholidays from the AIM Team! May this season bring you warmth, joy, and moments of peace with those who matter most.
-
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards
aimimmuno.com/aim-immunotech-announces-notification-of-no…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Election of Three Incumbent Board Members at Annual Meeting
aimimmuno.com/aim-immunotech-announces-election-of-three-…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Stay updated with $AIM by signing up for email alerts here: aimimmuno.com/email-alerts/
#pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Reminds Shareholders to Vote “FOR” All Four Incumbent Board Members on the WHITE Universal Proxy Card
aimimmuno.com/aim-immunotech-reminds-shareholders-to-vote…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
We are Advancing an Innovative Pipeline Across Multiple High-Value Disease Areas
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Urges Shareholders to Vote on the WHITE Universal Proxy Card “FOR” All Four Incumbent Board Members
aimimmuno.com/aim-immunotech-urges-shareholders-to-vote-o…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Expands Patent Portfolio with New Netherlands Composition and Methods Patent Covering Ampligen for Use in the Post-COVID Condition of Fatigue
aimimmuno.com/aim-immunotech-expands-patent-portfolio-wit…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Glass Lewis Recommends AIM ImmunoTech Shareholders Vote “FOR” Company Nominees Nancy K. Bryan, Thomas K. Equels and Dr. William M. Mitchell
aimimmuno.com/glass-lewis-recommends-aim-immunotech-share…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
We are Unlocking the Value of Ampligen.
aimimmuno.com/ampligen/"
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
For the past 2 years, Ted Kellner has led a costly and distracting campaign to mislead $AIM shareholders and take control of the @aimimmuno Board. His plan to repay the Activist Group with AIM’s capital for their failed 2023 Board takeover must be stopped. Learn more:
-
AIM ImmunoTech
@AimImmuno
Todd Deutsch has been part of the Activist Group’s multi-year effort to take control of the $AIM Board of Directors. Learn more about how you can protect your investment in @aimimmuno:
-
AIM ImmunoTech reposted
Virtual Investor Co.
@InvestorVirtual
AIM ImmunoTech Participates in Virtual Investor KOL Connect Segment, featuring Dr. Charles Lapp, ME/CFS Key Opinion Leader and founder of the Hunter-Hopkins Center
vimeo.com/1036547942/ef83ede6c9?share=copy
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Participates in Virtual Investor KOL Connect Segment
aimimmuno.com/aim-immunotech-participates-in-virtual-inve…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
After being fired as CEO of Rockwell Medical for “sustained mismanagement” and “blatant disregard for shareholder concerns,” we believe Robert Chioini is unfit to serve as a public company director, let alone CEO of $AIM. Learn how to support current leadership:
-
AIM ImmunoTech
@AimImmuno
We $AIM to Develop Better Treatment Options. Learn more about our ongoing efforts here: aimimmuno.com/pipeline/
#pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Ted Kellner claims to be the “largest investor in almost every deal” put together by fellow nominee Paul Sweeney’s PE firm, PS Capital Partners. We believe these financial interconnections would prevent them from serving independently on $AIM’s Board. Learn more:
-
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Issues Presentation Detailing Why Shareholders Should NOT Elect Activist Group’s Nominees to the Board
aimimmuno.com/aim-immunotech-issues-presentation-detailin…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Cash Conservation Plan
aimimmuno.com/aim-immunotech-announces-cash-conservation-…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid -
AIM ImmunoTech
@AimImmuno
Advancing Therapeutic Solutions: Our lead program, Ampligen®, is an immuno-modulator demonstrating broad activity and is currently being evaluated in clinical trials for a range of serious conditions. Learn more: aimimmuno.com/ampligen/
$AIM -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Issues Presentation Detailing Case for Re-Electing Current Directors to Oversee Continued Momentum and Drive Strategy to Create Long-Term Value for Patients and Shareholders
aimimmuno.com/aim-immunotech-issues-presentation-detailin…
$AIM #pancsm #ovaca #breastcancer #colorectalcancer #longcovid -
AIM ImmunoTech
@AimImmuno
#pancreaticcancer is the fourth leading cause of cancer-related deaths in the U.S. Each year, around 60% of cases are diagnosed at an advanced stage, highlighting the importance of early detection and research. Join us in advocating for awareness and support.
$AIM -
AIM ImmunoTech
@AimImmuno
Our goal is to unleash the cellular immune response to attack and destroy cancer cells and increase survival. Find out more here: aimimmuno.com/ampligen/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid -
AIM ImmunoTech
@AimImmuno
It’s World Pancreatic Cancer Day! Let’s shine a light on #pancreaticcancer and support those affected by this disease. Together, we can raise awareness and advocate for a cure. Learn more and get involved: www.aacr.org/patients-caregivers/awareness-months/pancrea…
$AIM #worldpancreaticcancerday -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Publication of Breast Cancer Data from Roswell Park Comprehensive Cancer Center in The Journal for ImmunoTherapy of Cancer
aimimmuno.com/aim-immunotech-announces-publication-of-bre…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid -
AIM ImmunoTech
@AimImmuno
For the third year in a row, a group of activist investors is attempting to take control of the @AIMImmuno Board and wants to use millions of dollars of shareholder capital to repay themselves for their failed 2023 Board takeover. Learn how to protect your investment.
$AIM -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Reports Third Quarter 2024 Financial Results and Provides Corporate Update
aimimmuno.com/aim-immunotech-reports-third-quarter-2024-f…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid -
AIM ImmunoTech
@AimImmuno
Each year, there are approximately 62,210 new cases of pancreatic cancer. Unfortunately, this disease accounts for about 49,830 deaths annually. Join us in raising awareness and supporting research for better outcomes in the fight against #pancreaticcancer.
$AIM -
AIM ImmunoTech
@AimImmuno
Check out our latest Virtual Investor CEO Connect segment to hear directly from our CEO, Tom Equels.
us02web.zoom.us/webinar/register/WN_BWkvtiOiR-urw_99ufePAQ
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid -
AIM ImmunoTech
@AimImmuno
For the third year in a row, a group of activist investors is attempting to take control of @AimImmuno’s Board. Their efforts would put the Company’s clinical progress and potential to enhance value for shareholders at risk. Learn more:
-
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech to Discuss Third Quarter 2024 Financial Results on November 15, 2024 and Host Conference Call and Webcast
aimimmuno.com/aim-immunotech-to-discuss-third-quarter-202…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Stay in the loop by signing up for email alerts. Register here: aimimmuno.com/email-alerts/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Files Definitive Proxy Statement and Sends Letter to Shareholders
aimimmuno.com/aim-immunotech-files-definitive-proxy-state…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
November is #pancreaticcancerawarenessmonth! Help us raise awareness and support those impacted by this terrible disease. Together, we can make a difference.
Learn more: www.aacr.org/patients-caregivers/awareness-months/pancrea…
$AIM #pancreaticcancer #pcam -
AIM ImmunoTech
@AimImmuno
As #breastcancerawarenessmonth comes to an end, we thank you for supporting the fight against #breastcancer. Keep advocating, get screened, and stay involved year-round. Learn more: www.nationalbreastcancer.org/breast-cancer-awareness-month/
#breastcancerawareness -
AIM ImmunoTech
@AimImmuno
Stay informed on AIM’s latest updates by signing up for our email alerts: aimimmuno.com/email-alerts/ to get news on #pancreaticcancer, #ovariancancer, #breastcancer, #colorectalcancer, #longcovid, and #mecfs.
-
AIM ImmunoTech
@AimImmuno
Aim Immunotech is dedicated to clinical execution and unlocking the full potential of our lead therapeutic candidate. aimimmuno.com/ampligen/ $AIM
-
AIM ImmunoTech
@AimImmuno
We are Advancing Immunology Solutions for a Better Future. aimimmuno.com
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Each year, there are ~287,000 new cases of breast cancer. Of these, 12-20% are diagnosed as triple-negative breast cancer, which is known for being more aggressive and having fewer treatment options. Join us in the fight against #breastcancer.
-
AIM ImmunoTech
@AimImmuno
We are led by a team of dedicated professionals with extensive pharmaceutical development expertise. Dive into our backgrounds here: aimimmuno.com/management-team/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC on Wednesday, October 16th at 12:30 PM ET
aimimmuno.com/aim-immunotech-to-participate-in-the-2024-h…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid -
AIM ImmunoTech
@AimImmuno
$AIM has a well-developed safety profile with clinical trials in multiple high-value disease areas. Take a look at our corporate presentation for more details. aimimmuno.com/presentations/
#pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
October is #breastcancerawarenessmonth! Join us in the fight against Breast Cancer. Together, we can raise awareness and work towards a cure. Learn more here: www.nationalbreastcancer.org/breast-cancer-awareness-month/
$AIM #breastcancerawareness #bcam -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Granted U.S. Patent for Ampligen® for the Treatment of Endometriosis
aimimmuno.com/aim-immunotech-granted-u-s-patent-for-ampli…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid -
AIM ImmunoTech
@AimImmuno
#tuneintoday for our participation in a Virtual Investor CEO Connect segment at 4 PM ET. Send your questions to aim@jtcir.com and register for the event at us02web.zoom.us/webinar/register/WN_BWkvtiOiR-urw_99ufePAQ
#pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid @Investorvirtual -
AIM ImmunoTech
@AimImmuno
Ovarian Cancer Awareness Month is coming to an end, but you can continue to raise awareness and take action. Learn more here: www.aacr.org/patients-caregivers/awareness-months/ovarian…
$AIM @AACR #ovariancancerawarenessmonth -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Pricing of $1.26 Million Registered Direct Offering
aimimmuno.com/aim-immunotech-announces-pricing-of-1-26-mi…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech to Participate in Virtual Investor CEO Connect Segment
aimimmuno.com/aim-immunotech-to-participate-in-virtual-in…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid -
AIM ImmunoTech
@AimImmuno
Stay updated on $AIM by signing up for our email alerts: aimimmuno.com/email-alerts/. Get the latest on #pancreaticcancer, #ovariancancer, #breastcancer, #colorectalcancer, #longcovid, and #mecfs!
-
AIM ImmunoTech
@AimImmuno
At AIM, we’re committed to using innovative methods to enhance our development pipelines and expand treatment options for patients. Discover more about our efforts here: aimimmuno.com/pipeline/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid -
AIM ImmunoTech
@AimImmuno
$AIM is focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19. Learn more here: aimimmuno.com/about/
#pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Reports Positive Preliminary Data in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer
aimimmuno.com/aim-immunotech-reports-positive-preliminary…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
#didyouknow: There were 19,880 estimated new cases of Ovarian Cancer in 2023. There were also 12,810 approximate deaths resulting from ovarian cancer in the United State in 2023. Join us in the fight against ovarian cancer: aimimmuno.com
$AIM #ovariancancer -
AIM ImmunoTech
@AimImmuno
Would you like to learn more about our approach? Explore more on our scientific publications page here: aimimmuno.com/scientific-publications/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces that Analysis of AMP-518 Complete Clinical Patient Data Underscores Ampligen’s Potential to Improve the Post-COVID Condition of Fatigue
aimimmuno.com/aim-immunotech-announces-that-analysis-of-a…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid -
AIM ImmunoTech
@AimImmuno
Interested in hearing more from our CEO, Tom Equels? Tune in to our CEO Corner to stay informed on our latest insights and developments. Check out previous segments here: aimimmuno.com/ceo-corner/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid -
AIM ImmunoTech
@AimImmuno
September is Ovarian Cancer Awareness Month! Follow along throughout the month as we raise awareness about this serious disease. Discover more about #ovariancancer and find out how you can get involved here: www.aacr.org/patients-caregivers/awareness-months/ovarian…
$AIM @AACR #ovariancancerawarenessmonth -
AIM ImmunoTech
@AimImmuno
$AIM is led by a team of dedicated professionals with extensive pharmaceutical development expertise. Together, we are focused on #immunology for a better future.
aimimmuno.com/management-team/
#pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Keeping our stockholders well-informed is a top priority. We launched our CEO corner to do just that. Catch up on previous segments here: aimimmuno.com/ceo-corner/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
We are committed to advancing our technology platforms and product candidates. In order to pursue this goal, we are highly interested in collaborative opportunities. If you are interested in exploring partnership opportunities, please contact us at info@AIMimmuno.com.
$AIM -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Print Publication and Further Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research
aimimmuno.com/aim-immunotech-announces-print-publication-…
$AIM #pancsm #ovaca #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Our corporate presentation contains everything about AIM – from our mission to our product pipeline and everything in between. View the latest here: aimimmuno.com/presentations/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Reports Second Quarter 2024 Financial Results and Provides Corporate Update
aimimmuno.com/aim-immunotech-reports-second-quarter-2024-…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech to Discuss Second Quarter 2024 Financial Results on August 16, 2024, and Host Conference Call and Webcast
aimimmuno.com/aim-immunotech-to-discuss-second-quarter-20…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
The best way to stay up to date on latest news and information from us is to sign up for our email alerts. Get notified by registering here: aimimmuno.com/email-alerts/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Our lead program is being evaluated in clinical studies for a range of debilitating and life-threatening conditions. Learn more here: aimimmuno.com/pipeline/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
#ceocorner: Tom Equels, CEO of $AIM, gives an overview of the Company’s work in early stage, triple-negative breast cancer. Tune in here: vimeo.com/991526150/90d88e0786
#breastcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
aimimmuno.com/aim-immunotech-announces-release-of-the-nex…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM Announces New Positive Data on Ampligen’s Anti-Tumor Potential When Used as Part of a Combination Therapy
aimimmuno.com/aim-announces-new-positive-data-on-ampligen…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Catch up on our previously released #ceocorner segments and keep an eye out for more! Have a topic for Tom? Enter your suggestion here: aimimmuno.com/ceo-corner/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Listen to our CEO, Tom Equels, give a “Quick Pitch” on the AIM opportunity at the recent Virtual Investor Pitch Conference.
Access the full webcast replay here: us02web.zoom.us/webinar/register/WN_Q3MB16lRTimDfV4dnML0mA
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Take a look at our latest corporate presentation here: aimimmuno.com/presentations/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Never miss an update by signing up for our email alerts. aimimmuno.com/email-alerts/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
#incaseyoumissedit: We recently participated in the Virtual Investor Pitch Conference! Access the webcast replay here: us02web.zoom.us/webinar/register/WN_Q3MB16lRTimDfV4dnML0mA
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Wishing everyone a happy Independence Day!
#4thofjuly2024 -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
aimimmuno.com/aim-immunotech-announces-release-of-the-nex…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
#incaseyoumissedit: We recently participated in the Virtual Investor Pitch Conference and the webcast replay is now available here: us02web.zoom.us/webinar/register/WN_Q3MB16lRTimDfV4dnML0mA
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Information. Access. Accountability. Visit our #ceocorner for valuable segments from our CEO, Tom Equels. aimimmuno.com/ceo-corner/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Take a look at our latest corporate presentation here: aimimmuno.com/presentations/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
$AIM ImmunoTech Inc. is an immuno-pharma company focused on advancing immunology solutions for a better future. Learn more here: aimimmuno.com/about/
#pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
#tuneintoday for the Virtual Investor Pitch Conference! Our CEO, Tom Equels will be presenting at 1 PM ET. Register here: bit.ly/3pTkXjP0
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
#tunein next week for the Virtual Investor Pitch Conference! Our CEO, Tom Equels will be presenting on Monday at 1 PM ET. Register here: virtualinvestorco.com
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Never miss an update by signing up for our email alerts. aimimmuno.com/email-alerts/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
#savethedate for the Virtual Investor Pitch Conference! Our CEO, Tom Equels will be presenting on Monday June 17 at 1 PM ET. Register here: virtualinvestorco.com
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech to Participate in the Virtual Investor Pitch Conference
aimimmuno.com/aim-immunotech-to-participate-in-the-virtua…
$AIM @InvestorVirtual #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
We are advancing a broad pipeline across a number of high-value therapeutic areas. Learn more here: aimimmuno.com/pipeline/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech to Participate in the Virtual Investor Lunch Break Series
aimimmuno.com/aim-immunotech-to-participate-in-the-virtua…
$AIM #pancreaticcancer #ovariancancer #breastcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Pricing of $2.0 Million Registered Direct Offering
aimimmuno.com/aim-immunotech-announces-pricing-of-2-0-mil…
$AIM #pancreaticcancer #ovariancancer #breastcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
#incaseyoumissedit: Our CEO, Tom Equels, recently presented at the LIVE! with Webull Corporate Connect: Biotech Investment Webinar. Watch the replay here: vimeo.com/951168590/392af99a79?share=copy
$AIM #pancreaticcancer #ovariancancer #breastcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Take a look at our latest corporate presentation here: aimimmuno.com/presentations/
$AIM #pancreaticcancer #ovariancancer #breastcancer#ColorectalCancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
#tuneintoday for the LIVE! with Webull Corporate Connect: Biotech Investment Webinar. Our CEO, Tom Equels, will be presenting at 3:40 PM ET. Register here: us02web.zoom.us/webinar/register/WN_2S9XAH89QiSR2Zd583r59Q
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
#happeningtomorrow: Our CEO, Tom Equels, will be presenting at 3:40 PM ET in the LIVE! with Webull Corporate Connect: Biotech Investment Webinar.
Register here: us02web.zoom.us/webinar/register/WN_2S9XAH89QiSR2Zd583r59Q
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Information. Access. Accountability.
Visit our #ceocorner for valuable segments from our CEO, Thomas Equels.
aimimmuno.com/ceo-corner/
$AIM #pancreaticcancer #ovariancancer #breastcancer#ColorectalCancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech to Participate in Two Upcoming Investor Conferences
aimimmuno.com/aim-immunotech-to-participate-in-two-upcomi…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Reports First Quarter 2024 Financial Results and Provides Corporate Update
aimimmuno.com/aim-immunotech-reports-first-quarter-2024-f…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Today is ME/CFS Awareness Day! Learn more about how $AIM is working to address this serious, long-term illness here: aimimmuno.com/immune-disorders/ and for more information on ME/CFS Awareness Day, visit: solvecfs.org/solve-a-globalvoiceforme-on-world-me-day-2024/
$AIM #mecfs #mecfsawarenessday #chronicfatigue -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech to Discuss First Quarter 2024 Financial Results on May 16, 2024, and Host Conference Call and Webcast
aimimmuno.com/aim-immunotech-to-discuss-first-quarter-202…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Today is #worldovariancancerday with a goal to highlight the issue of ovarian cancer around the globe. We will continue to try to reach a world where no woman dies of ovarian cancer. Learn more here: worldovariancancercoalition.org/world-ovarian-cancer-day/
$AIM #ovaca #ovariancancer #ovariancancerawareness -
AIM ImmunoTech
@AimImmuno
Never miss an update by signing up for our email alerts.
aimimmuno.com/email-alerts/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Completes cGMP Manufacturing of Clinical Vials of Ampligen®
aimimmuno.com/aim-immunotech-completes-cgmp-manufacturing…
$AIM #ceocorner #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces First Dose Level is Generally Well-Tolerated in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer
aimimmuno.com/aim-immunotech-announces-first-dose-level-i…
$AIM #pancreaticcancer #oncology -
AIM ImmunoTech
@AimImmuno
Have you seen our #ceocorner with Tom Equels, our Chief Executive Officer? He provides additional and in-depth perspective to press releases, corporate developments and development pipeline progress.
aimimmuno.com/ceo-corner/ -
AIM ImmunoTech
@AimImmuno
#ceocorner: Tom Equels, CEO of $AIM, gives an overview of Metastatic Pancreatic Cancer and AIM’s Collaboration with AstraZeneca (DURIPANC). Tune in here: vimeo.com/928555882/8d657f5e63?share=copy
#pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
aimimmuno.com/aim-immunotech-announces-release-of-the-nex…
$AIM #ceocorner #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Never miss an update by signing up for our email alerts.
aimimmuno.com/email-alerts/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
#ceocorner: Our CEO, Tom Equels, gives an overview of Locally Advanced Pancreatic Adenocarcinoma and the unmet need. Tune in here: vimeo.com/936259045/29e48162f6?share=copy
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
aimimmuno.com/aim-immunotech-announces-release-of-the-nex…
$AIM #pancreaticcancer #ceocorner -
AIM ImmunoTech
@AimImmuno
Information. Access. Accountability. Visit our #ceocorner for valuable segments from our CEO, Thomas Equels.
aimimmuno.com/ceo-corner/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Charles Lapp, MD, as a Consulting Medical Officer for its ME/CFS and Long COVID Programs
aimimmuno.com/aim-immunotech-announces-charles-lapp-md-as…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
#ceocorner – Our CEO, Tom Equels, discusses our recent news regarding the positive top-line interim data from our ongoing study in recurrent ovarian cancer.
vimeo.com/933287801/6bffca7f62?share=copy
$AIM #ovariancancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
aimimmuno.com/aim-immunotech-announces-release-of-the-nex…
$AIM #ceocorner #ovariancancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Positive Top-Line, Protocol-Planned Interim Report Data from the Study of Ampligen Combined with Pembrolizumab for the Treatment of Recurrent Ovarian Cancer
aimimmuno.com/aim-immunotech-announces-positive-top-line-…
$AIM #ovariancancer -
AIM ImmunoTech
@AimImmuno
Take a look at our latest corporate presentation here: aimimmuno.com/presentations/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
April is #cancercontrolmonth. The aim is to focus on the importance of improving cancer treatments and increasing the survival rate of cancer. Learn more here: www.nfcr.org/blog/cancer-control-month-how-you-can-make-a…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
aimimmuno.com/aim-immunotech-reports-fourth-quarter-and-f…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
#didyouknow: About 1 in every 71 women in the United States will develop ovarian cancer.
$AIM #oncology #ovariancancer #ovaca -
AIM ImmunoTech
@AimImmuno
#incaseyoumissedit We recently participated in the Virtual Investor Lunch Break: The AIM Opportunity event. Watch the replay here: us02web.zoom.us/webinar/register/WN_PoZHz3mUSvaj_j4qnMhqsw
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023 Financial Results on April 2, 2024, and Host Conference Call and Webcast
aimimmuno.com/aim-immunotech-to-discuss-fourth-quarter-an…
$AIM #pancsm #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Publication of Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research
aimimmuno.com/aim-immunotech-announces-publication-of-pos…
$AIM #pancsm #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
aimimmuno.com/aim-immunotech-announces-release-of-the-nex…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Never miss an update by signing up for our email alerts.
aimimmuno.com/email-alerts/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
aimimmuno.com/aim-immunotech-announces-release-of-the-nex…
$AIM #ceocorner #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
#ceocorner! View the latest segment of our CEO Corner featuring Tom Equels here: vimeo.com/925382650/8421a8c9bd?share=copy
Tom provides a deep dive into our Phase 2 trial in advanced recurrent #ovariancancer.
$AIM #pancreaticcancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
#tuneintomorrow for the Virtual Investor Lunch Break: The AIM Opportunity at 12 PM ET. Register here: us02web.zoom.us/webinar/register/WN_PoZHz3mUSvaj_j4qnMhqsw
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
#savethedate for the Virtual Investor Lunch Break: The AIM Opportunity on March 20 at 12 PM ET. Register here: us02web.zoom.us/webinar/register/WN_PoZHz3mUSvaj_j4qnMhqsw
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM is targeting a number of high-value therapeutic areas including oncology.
aimimmuno.com/pipeline/
$AIM #colorectalcancerawarenessmonth #oncology #colorectalcancer -
AIM ImmunoTech
@AimImmuno
#didyouknow: It is estimated that about 66,440 people will be diagnosed with pancreatic cancer this year.
$AIM #oncology #pancreaticcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech to Participate in the Virtual Investor Lunch Break: The AIM Opportunity
aimimmuno.com/aim-immunotech-to-participate-in-the-virtua…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
#ceocorner! The significant potential of Ampligen in a number of high-value #oncology indications. Listen to our CEO, Tom Equels, give an overview of our oncology program!
vimeo.com/922924184/c526e90e51?share=copy
$AIM #pancsm #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Take a look at our latest corporate presentation here: aimimmuno.com/presentations/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
March is National #colorectalcancerawarenessmonth. Learn more about how you can get involved here: socialpresskit.com/colorectal-cancer-alliance
$AIM #oncology #colorectalcancer -
AIM ImmunoTech
@AimImmuno
We are pleased to kick off our CEO Corner featuring our CEO, Thomas Equels! Access the CEO corner here: aimimmuno.com/ceo-corner/ and be on the lookout for series of videos covering important topics about all things $AIM.
#ceocorner -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Launch of CEO Corner Platform
aimimmuno.com/aim-immunotech-announces-launch-of-ceo-corn…
$AIM #ceocorner #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Outlines Recent Progress Across Clinical Development Pipeline and Provides Business Update
aimimmuno.com/aim-immunotech-outlines-recent-progress-acr…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Never miss an update by signing up for our email alerts.
aimimmuno.com/email-alerts/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
We are advancing a broad pipeline across a number of high-value therapeutic areas. Take a look at our priority development pipeline here: aimimmuno.com/pipeline/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
We are led by a team of dedicated professionals with extensive pharmaceutical development expertise. Meet our Management Team here: aimimmuno.com/management-team/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Our lead program has shown broad spectrum activity in in-vitro and animal testing and is being evaluated in clinical studies for a range of debilitating and life-threatening conditions.
aimimmuno.com/about/
$AIM #pancsm #ovaca #bcsm #crcsm #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces First Subject Dosed in the Netherlands for Phase 1b/2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi (durvalumab) for the Treatment of Pancreatic Cancer
aimimmuno.com/aim-immunotech-announces-first-subject-dose…
#pancreaticcancer -
AIM ImmunoTech
@AimImmuno
Take a look at our latest corporate presentation here: aimimmuno.com/presentations/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech reposted
Virtual Investor Co.
@InvestorVirtual
#whatthismeans - #positivetoplineresults: Dr. Chris McAleer, Scientific Officer of $AIM Immunotech, discusses the Company’s Positive Topline Results from Phase 2 Study Evaluating Ampligen® for the Treatment of Post-COVID Conditions.
vimeo.com/911584110/729efa1a02?share=copy
#longcovid -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Reports Positive Topline Results from Phase 2 Study Evaluating Ampligen® for the Treatment of Post-COVID Conditions
aimimmuno.com/aim-immunotech-reports-positive-topline-res…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
February 4th is #worldcancerday and the theme is #closethecaregap. Learn more and get involved here: www.worldcancerday.org
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
Our lead product candidate’s mechanism of action works through reprogramming of the tumor microenvironment to convert “cold” tumors into “hot” tumors that will be responsive to checkpoint blockage.
aimimmuno.com/ampligen/
$AIM #pancsm #ovaca #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
Stay up to date on all things AIM by signing up for our email alerts.
aimimmuno.com/email-alerts/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Receives Erasmus Medical Center Ethics Board Authorization for Phase 2 Study of Ampligen® for the Treatment of Locally Advanced #pancreaticcancer.
aimimmuno.com/aim-immunotech-receives-erasmus-medical-cen…
$AIM #oncology -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces that the First Subject is Enrolled in the Phase 1b/2 Study Evaluating Ampligen® in Combination with AstraZeneca’s Imfinzi® for the Treatment of Late-Stage #pancreaticcancer
aimimmuno.com/aim-immunotech-announces-that-the-first-sub…
$AIM -
AIM ImmunoTech
@AimImmuno
Take a look at our latest corporate presentation here: aimimmuno.com/presentations/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases.
aimimmuno.com/about/
$AIM #pancsm #ovaca #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Open Enrollment for Phase 1b/2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer
aimimmuno.com/aim-immunotech-announces-open-enrollment-fo…
$AIM #pancreaticcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech is committed to advancing our broad pipeline in order to provide immunology for a better future. Learn more about our mission here: aimimmuno.com
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM Shareholders Elect All Four Company Director Nominees at 2023 Annual Meeting
aimimmuno.com/aim-shareholders-elect-all-four-company-dir…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Learn about our AIM in Immuno-Oncology here: aimimmuno.com/immuno-oncology/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Over the course of 2023, we’ve proven our resilience and our dedication to immunology for a better future. We are excited to see what 2024 brings! $AIM
-
AIM ImmunoTech
@AimImmuno
Delaware Court Rules in Favor of AIM ImmunoTech and Upholds Board’s Determination that Activist Group’s Nominations Are Invalid
aimimmuno.com/delaware-court-rules-in-favor-of-aim-immuno…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Happy holidays from the $AIM team! Wishing you all happiness and time spent with those you care about.
-
AIM ImmunoTech
@AimImmuno
Stay up to date on all things $AIM by signing up for our email alerts.
aimimmuno.com/email-alerts/
#pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
We are led by a team of dedicated professionals with extensive pharmaceutical development expertise. Meet our team here: aimimmuno.com/management-team/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases.
aimimmuno.com/about/
$AIM #pancsm #ovaca #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Take a look at our latest corporate presentation here: aimimmuno.com/presentations/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
We are advancing a broad pipeline across a number of high-value therapeutic areas. Take a look at our pipeline here: aimimmuno.com/pipeline/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Stay up to date on all things $AIM by signing up for our email alerts.
aimimmuno.com/email-alerts/
#pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Provides Update Regarding Annual Meeting
aimimmuno.com/aim-immunotech-provides-update-regarding-an…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech reposted
Virtual Investor Co.
@InvestorVirtual
#patentissuance - #whatthismeans: CEO of $AIM, Tom Equels, discusses the Company’s recent news: Bolstering intellectual property estate for Ampligen® with issuance of two key U.S. Patents.
vimeo.com/888443063/90896380dd?share=copy
@AimImmuno #panccancer #ovaca #bcsm #crcsm #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Bolsters Intellectual Property Estate for Ampligen® with Issuance of Two Key U.S. Patents
aimimmuno.com/aim-immunotech-bolsters-intellectual-proper…
$AIM PancreaticCancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Have a Happy Thanksgiving! Hoping your Thanksgiving is filled with friends, family and joy! $AIM
-
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Completes Treatment of Last Subject in Phase 2 Study Evaluating Ampligen® for the Treatment of Post-COVID Conditions
aimimmuno.com/aim-immunotech-completes-treatment-of-last-…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
For more information on #pancreaticcancerawarenessmonth and ways you can get involved, visit: www.aacr.org/patients-caregivers/awareness-months/pancrea…
$AIM #pcam #pancreaticcancer -
AIM ImmunoTech
@AimImmuno
Learn more about what we are doing to address #pancreaticcancer here: aimimmuno.com/pipeline/
$AIM #pancreaticcancerawarenessmonth #pcam -
AIM ImmunoTech
@AimImmuno
November 16 is #worldpancreaticcancerday. Learn more about how you can #getinvolved here: pancan.org/news/5-ways-to-take-action-on-world-pancreatic…
$AIM #pancreaticcancerawareness #pancreaticcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Reports Third Quarter 2023 Financial Results and Provides Clinical Pipeline Update
aimimmuno.com/aim-immunotech-reports-third-quarter-2023-f…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
$AIM is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases.
aimimmuno.com/about/
#pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Publication of Data from Roswell Park Comprehensive Cancer Center Phase 1 Study Evaluating Ampligen® as a Component of a Chemokine-Modulating (CKM) Regimen in Metastatic Triple-Negative Breast Cancer
aimimmuno.com/aim-immunotech-announces-publication-of-dat…
$AIM #breastcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech to Discuss Third Quarter 2023 Financial Results on November 15, 2023 and Host Conference Call and Webcast
aimimmuno.com/aim-immunotech-to-discuss-third-quarter-202…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
We are led by a team of dedicated professionals with extensive pharmaceutical development expertise.
aimimmuno.com/management-team/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Encouraging Translational Data from Phase 2 Study Evaluating Ampligen® for the Treatment of Advanced Recurrent Ovarian Cancer
aimimmuno.com/aim-immunotech-announces-encouraging-transl…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Files Definitive Proxy Statement and Sends Letter to Shareholders
aimimmuno.com/aim-immunotech-files-definitive-proxy-state…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
November is #pancreaticcancerawarenessmonth. Join us as we raise awareness all month long about this terrible disease.
www.aacr.org/patients-caregivers/awareness-months/pancrea… $AIM #pancreaticcancer #pcam -
AIM ImmunoTech
@AimImmuno
#breastcancerawarenessmonth comes to a close, but we continue to advance immunology solutions for a better future.
aimimmuno.com/immuno-oncology/
$AIM #breastcancer #bcam #morethanbcam -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting
aimimmuno.com/aim-immunotech-announces-abstract-accepted-…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Stay up to date on all things AIM by signing up for our email alerts.
aimimmuno.com/email-alerts/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
According to the CDC, #breastcancer is the second most common cancer among women in the United States. Read more here: www.cdc.gov/cancer/breast/basic_info/index.htm
$AIM #breastcancerawarenessmonth #breastcancer #bcam #morethanbcam -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Engages Business Development Firm, Azenova, LLC to Catalyze Partnering, Development and Commercialization Efforts for Ampligen® Pipeline Programs
aimimmuno.com/aim-immunotech-engages-business-development…
$AIM #panccancer #ovaca #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
Today is Metastatic Breast Cancer Awareness Day. Learn more about what we are doing to address #breastcancer here: aimimmuno.com/immuno-oncology/
$AIM @NBCF #metastaticbreastcancerawarenessday #bcam #morethanbcam -
AIM ImmunoTech
@AimImmuno
We know that to help those facing breast cancer, awareness alone isn’t enough. This October, get involved and take action. Find out more here: www.nationalbreastcancer.org/breast-cancer-awareness-month/
$AIM @NBCF
#breastcancerawarenessmonth #breastcancer #bcam #morethanbcam -
AIM ImmunoTech
@AimImmuno
During the 31 days of #breastcancerawarenessmonth, pink ribbons represent the impact of breast cancer and help raise awareness as a national symbol. Get involved here: www.nationalbreastcancer.org/breast-cancer-awareness-month/
$AIM @NBCF
#breastcancerawarenessmonth #breastcancer #bcam #morethanbcam -
AIM ImmunoTech
@AimImmuno
October is Breast Cancer Awareness Month with a goal to spread awareness about breast cancer and the importance of getting screened.
www.nationalbreastcancer.org/breast-cancer-awareness-month/
$AIM @NBCF
#breastcancerawarenessmonth #breastcancer #bcam #morethanbcam -
AIM ImmunoTech
@AimImmuno
Our lead product candidate’s mechanism of action works through reprogramming of the tumor microenvironment to convert “cold” tumors into “hot” tumors that will be responsive to checkpoint blockage.
aimimmuno.com/ampligen/
#panccancer #ovaca #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
According to the National Cancer Institute, in 2023 more than 106,000 women in the United States are expected to be diagnosed with a gynecological cancer. Learn more here: www.aacr.org/patients-caregivers/awareness-months/gynecol…
$AIM @AACR #gynecologicalcancerawarenessmonth -
AIM ImmunoTech
@AimImmuno
Our CEO, Thomas Equels, gives insight into additional collaborations the Company may be interested in. Access the full webcast replay here: us02web.zoom.us/webinar/register/WN_0G3XmvgQQOmh5U4LSXYrXQ
$AIM @InvestorVirtual #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
About 1.3 percent of women will be diagnosed with ovarian cancer at some point in their life, according to data from the NCI’s Surveillance, Epidemiology, and End Results Program. Learn more here: www.aacr.org/patients-caregivers/awareness-months/ovarian…
$AIM @AACR #ovariancancer #ovariancancerawarenessmonth -
AIM ImmunoTech
@AimImmuno
Stay up to date on all things $AIM by signing up for our email alerts.
aimimmuno.com/email-alerts/
#pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Selected to Present at the 3rd Annual Marie Sklodowska-Curie Symposium on Cancer Research and Care
aimimmuno.com/aim-immunotech-selected-to-present-at-the-3…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Today is World Gynecologic Oncology Day. This year’s motto is GO for Testing. GO for Prevention. GO for the right Treatment. Learn more here: www.worldgoday.org
$AIM @WorldGOday #gofortesting #goforprevention #worldgoday #goforpurple -
AIM ImmunoTech
@AimImmuno
Our CEO, Thomas Equels, expresses excitement for the rest of the year and gives us a look at what investors can expect in the future.
us02web.zoom.us/webinar/register/WN_0G3XmvgQQOmh5U4LSXYrXQ
$AIM @InvestorVirtual #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM Immunotech is targeting multiple cancers with high unmet need such as ovarian cancer. aimimmuno.com/immuno-oncology/
$AIM #ovariancancerawarenessmonth -
AIM ImmunoTech
@AimImmuno
September is Ovarian Cancer Awareness Month. Join us all month long as we bring awareness to this deadly disease. Learn more about #ovariancancer and how you can get involved here: www.aacr.org/patients-caregivers/awareness-months/ovarian…
$AIM @AACR #ovariancancerawarenessmonth -
AIM ImmunoTech
@AimImmuno
$AIM Announces Report of Complete Topline Data from Roswell Park Comprehensive Cancer Center Study Evaluating Ampligen® as a Component of a Chemokine-Modulating Regimen, with Paclitaxel, for the Treatment of Early-Stage Triple Negative Breast Cancer
aimimmuno.com/aim-immunotech-announces-report-of-complete… -
AIM ImmunoTech
@AimImmuno
September is Gynecologic Cancer Awareness Month with a goal to spread awareness about gynecological cancers and the importance of getting tested.
www.aacr.org/patients-caregivers/awareness-months/gynecol… $AIM @AACR
#gynecologicalcancerawarenessmonth -
AIM ImmunoTech
@AimImmuno
We are participating in the H.C. Wainwright 25th Annual Global Investment Conference! View our presentation on demand by visiting journey.ct.events/view/ea56ee2c-19f6-4015-83f1-82622e880f4e
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech to Present at the H.C. Wainwright 25th Annual Global Investment Conference.
aimimmuno.com/aim-immunotech-to-present-at-the-h-c-wainwr…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Take a look at our latest corporate presentation here: aimimmuno.com/presentations/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Our CEO, Thomas Equels, describes why we are confident we have the potential for success in pancreatic cancer. Access the full webcast replay here: us02web.zoom.us/webinar/register/WN_0G3XmvgQQOmh5U4LSXYrXQ
$AIM @InvestorVirtual #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Rejects Director Nomination Notice from Activist Group Due to Numerous Material Defects, Omissions and False and Misleading Statements
aimimmuno.com/aim-immunotech-rejects-director-nomination-…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Dr. Chris McAleer, Scientific Officer at $AIM, walks us through the mechanism of action of Ampligen and describes additional oncology applications at the recent Virtual Investor Summer Spotlight Series.
us02web.zoom.us/webinar/register/WN_0G3XmvgQQOmh5U4LSXYrXQ -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Reports Second Quarter Financial Results and Provides Clinical Pipeline Update
aimimmuno.com/aim-immunotech-reports-second-quarter-finan…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Stay up to date on all things $AIM by signing up for our email alerts. aimimmuno.com/email-alerts/
#pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Completion of Enrollment in Phase 2 Study Evaluating Ampligen® for the Treatment of Post-COVID Conditions
aimimmuno.com/aim-immunotech-announces-completion-of-enro…
$AIM #covid #longhaulers #postcovid -
AIM ImmunoTech
@AimImmuno
Our CEO, Thomas Equels, provides a corporate overview of the Company at the recent @InvestorVirtual Summer Spotlight Series. Access the full webcast replay here: us02web.zoom.us/webinar/register/WN_0G3XmvgQQOmh5U4LSXYrXQ
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
#incaseyoumissedit we recently participated in the Virtual Investor Summer Spotlight Series. Watch the video webcast replay here: us02web.zoom.us/webinar/register/WN_0G3XmvgQQOmh5U4LSXYrXQ
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Take a look at our latest corporate presentation here: aimimmuno.com/presentations/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Stay up to date on all things AIM by signing up for our email alerts.
aimimmuno.com/email-alerts/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
#happeningtoday! Join us at 11 AM ET for our participation in the Virtual Investor Summer Spotlight Series. Access the event here: us02web.zoom.us/webinar/register/WN_0G3XmvgQQOmh5U4LSXYrXQ
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
#tuneintomorrow for our participation in the Virtual Investor Summer Spotlight Series at 11 AM ET. Register for the event here: us02web.zoom.us/webinar/register/WN_0G3XmvgQQOmh5U4LSXYrXQ
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
#markyourcalendars for our participation in the upcoming Virtual Investor Summer Spotlight Series on July 12 at 11 AM ET. Register for the event here: us02web.zoom.us/webinar/register/WN_0G3XmvgQQOmh5U4LSXYrXQ
#pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Enrolls and Doses First Subject in Phase 2 Study Evaluating Ampligen® for the Treatment of Post-COVID Conditions
aimimmuno.com/aim-immunotech-enrolls-and-doses-first-subj…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech to Participate in the Virtual Investor Summer Spotlight Series
aimimmuno.com/aim-immunotech-to-participate-in-the-virtua…
$AIM @InvestorVirtual #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Wishing you all a happy Independence Day! $AIM
-
AIM ImmunoTech
@AimImmuno
AIM Immuno Announces Authorizations from Competent Authority and Ethics Board in the Netherlands to Begin a Phase 1b/2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi (durvalumab) for the Treatment of Pancreatic Cancer
aimimmuno.com/aim-immunotech-announces-authorizations-fro… -
AIM ImmunoTech
@AimImmuno
Take a look at our latest corporate presentation here: aimimmuno.com/presentations/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
We will be presenting in the Healthcare Virtual Conference presented by Maxim today at 12 PM ET!
m-vest.com/events/healthcare-06202023
$AIM @MaximGrp #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
We will be participating in the Healthcare Virtual Conference presented by Maxim happening June 20 & 21!
m-vest.com/events/healthcare-06202023
$AIM @MaximGrp #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
We are advancing immunology solutions for a better future. Discover more about our science here: aimimmuno.com/pipeline/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech to Participate in the Healthcare Virtual Conference Presented by @MaximGrp and Hosted by @MVestllc
aimimmuno.com/aim-immunotech-to-participate-in-the-health…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Stay up to date on all things AIM by signing up for our email alerts.
aimimmuno.com/email-alerts/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Dive into our immuno-oncology clinical studies here: aimimmuno.com/immuno-oncology-2/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
We are thankful for those who gave their lives in defense of the United States of America. May their bravery and devotion not be forgotten.#memorialday2023
-
AIM ImmunoTech
@AimImmuno
Chronic illness following COVID-19 shares similar characteristics to ME/CFS. Learn more here: aimimmuno.com/immune-disorders/
#mecfs $AIM -
AIM ImmunoTech
@AimImmuno
Stay up to date on all things AIM by signing up for our email alerts.
aimimmuno.com/email-alerts/
#pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs $AIM -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Reports First Quarter Financial Results and Provides Pipeline Update
aimimmuno.com/aim-immunotech-reports-first-quarter-financ…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Happy Mother’s Day!
#mothersday2023 -
AIM ImmunoTech
@AimImmuno
May 12 is Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) International Awareness Day. We stand together with the millions of people living with ME/CFS.
www.cdc.gov/me-cfs/resources/awarenessday.html
#mecfs $AIM -
AIM ImmunoTech
@AimImmuno
ME/CFS International Awareness Day is coming up! Show support for people with ME/CFS, their families and caregivers and researchers who study ME/CFS by wearing blue on May 12.
www.cdc.gov/me-cfs/resources/awarenessday.html
#wearblueforme #mecfs $AIM -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech to Discuss First Quarter 2023 Financial Results on May 16, 2023 and Host Conference Call and Webcast
aimimmuno.com/aim-immunotech-to-discuss-first-quarter-202…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
May 8th is #worldovariancancerday! Join us as we raise awareness in the fight against ovarian cancer. Learn more about how to get involved here: worldovariancancercoalition.org/world-ovarian-cancer-day/
#nowomanleftbehind #ovaca #wocd2023 $AIM -
AIM ImmunoTech
@AimImmuno
Learn about our lead product candidate being developed for Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS).
aimimmuno.com/immune-disorders/
#mecfs $AIM -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech is committed to advancing our broad pipeline in order to provide immunology for a better future. Learn more about our mission here: aimimmuno.com
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Stay up to date on all things $AIM by signing up for our email alerts.
aimimmuno.com/email-alerts/
#pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
We recently launched our new website. As we work to advance our broad pipeline it was important for us to have a website that aligns with mission and vision going forward. Check it out here: aimimmuno.com
$AIM #ovariancancer #breastcancer #colorectalcancer #longc ... -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Appoints Preeminent Biotechnology Pioneer, W. Neal Burnette, Ph.D., as Chairman of its Scientific Advisory Board (SAB)
aimimmuno.com/aim-immunotech-appoints-preeminent-biotechn…
#pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs $AIM -
AIM ImmunoTech
@AimImmuno
Today is #worldhealthday and the 75th anniversary for @WHO! $AIM is committed to improving #healthforall.
#who75 -
AIM ImmunoTech
@AimImmuno
We are pleased to unveil our new website! Check it out at aimimmuno.com
#pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs $AIM -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Central IRB Approval of Phase 2 Study Protocol Evaluating Ampligen® for the Treatment of Post-COVID Conditions
aimimmuno.com/aim-immunotech-announces-central-irb-approv…
#postcovid #longcovid $AIM -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update.
aimimmuno.com/aim-immunotech-reports-fourth-quarter-and-f…
#cancer #longcovid #mecfs $AIM -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Bolsters Board of Directors with Appointment of Pharmaceutical Industry Veteran Nancy K. Bryan, with Deep Commercial, Marketing, Business Development and Corporate Finance Expertise
aimimmuno.com/press-release/aim-immunotech-bolsters-board…
#cancer #longcovid #mecfs $AIM -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech to Report Full Year 2022 Financial Results on March 31, 2023 and Host Inaugural Quarterly Conference Call and Webcast
aimimmuno.com/press-release/aim-immunotech-to-report-full…
#pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs $AIM -
AIM ImmunoTech
@AimImmuno
Our CEO, Tom Equels, explains why AIM ImmunoTech is a company to watch in 2023. Watch the full replay here: us02web.zoom.us/webinar/register/WN_k3GOjPkJRCGa_bOi_SLfwA
$AIM #virtualinvestor #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Late-Breaking Presentation at the International Conference on Antiviral Research Regarding Ampligen as a Potential Therapy Against Ebola Virus Disease
aimimmuno.com/press-release/aim-immunotech-announces-late…
$AIM -
AIM ImmunoTech
@AimImmuno
In 2023, an estimated 153,020 people will be diagnosed with #colorectalcancer. Get involved in the cause here: colorectalcancer.org/get-involved/advocate/colorectal-can…
@CCAlliance $AIM #colorectalcancerawarenessmonth -
AIM ImmunoTech
@AimImmuno
Stay up to date on all things AIM by signing up for our email alerts.
aimimmuno.com/email-alerts/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Our CEO, Tom Equels, provides a brief corporate overview. Access the full video webcast replay here: us02web.zoom.us/webinar/register/WN_k3GOjPkJRCGa_bOi_SLfwA
$AIM #virtualinvestor #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Publication of New Analysis of the Mechanism of Action of Ampligen as a Potential Prophylactic Therapy Against Ebola Virus Disease
aimimmuno.com/press-release/aim-immunotech-announces-publ… -
AIM ImmunoTech
@AimImmuno
March is National Colorectal Cancer Awareness Month. Join us as we bring awareness to this highly preventable disease. Learn more about how you can get involved here: colorectalcancer.org/get-involved/advocate/colorectal-can…
$AIM @CCAlliance #colorectalcancerawarenessmonth -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Issues Letter to Stockholders
aimimmuno.com/press-release/aim-immunotech-issues-letter-…
$AIM #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Phase 2 Study of Ampligen® for the Treatment of Pancreatic Cancer is Open and Recruiting Patients.
aimimmuno.com/press-release/aim-immunotech-announces-phas…
$AIM #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
Our CEO, Tom Equels, explains why AIM ImmunoTech is a company to watch in 2023. Watch the full replay here: us02web.zoom.us/webinar/register/WN_k3GOjPkJRCGa_bOi_SLfwA
@InvestorVirtual $AIM #virtualinvestor -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech to Participate in Solve M.E. and The Biotechnology Innovation Organization (BIO) Virtual Event, “Long Covid: What Will It Take To Accelerate Therapeutic Progress?”
aimimmuno.com/press-release/aim-immunotech-to-participate…
$AIM #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
We believe there is a critical unmet need for additional therapies to expand treatment options for cancer.
aimimmuno.com/pipeline/
#ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
We continue to make great strides. Listen to our CEO, Tom Equels, present at the recent Virtual Investor 2023 Companies to Watch event here: us02web.zoom.us/webinar/register/WN_k3GOjPkJRCGa_bOi_SLfwA
@InvestorVirtual $AIM #virtualinvestor -
AIM ImmunoTech
@AimImmuno
Stay up to date on all things AIM by signing up for our email alerts.
aimimmuno.com/email-alerts/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Our CEO, Tom Equels, gives a brief overview of our lead program at the recent Virtual Investor 2023 Companies to Watch Event. Watch the full replay here: us02web.zoom.us/webinar/register/WN_k3GOjPkJRCGa_bOi_SLfwA
@InvestorVirtual $AIM #virtualinvestor -
AIM ImmunoTech
@AimImmuno
Today is World Cancer Day! Find out how you can support the cause and get involved here: www.worldcancerday.org/about
$AIM #worldcancerday -
AIM ImmunoTech
@AimImmuno
February is Cancer Prevention Month. AIM is committed to developing therapies to expand treatment options for cancer patients. Find out more about how you can get involved here: www.worldcancerday.org
$AIM #cancerpreventionmonth -
AIM ImmunoTech
@AimImmuno
In case you missed it: Earlier this month, we participated in the 2023 Virtual Investor Companies to Watch Event. Access the webcast replay here: us02web.zoom.us/webinar/register/WN_k3GOjPkJRCGa_bOi_SLfwA
#pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
We are advancing our lead program for a significant unmet need in the treatment of #pancreaticcancer. $AIM
-
AIM ImmunoTech
@AimImmuno
Immunology for a better future. $AIM is engaged in the clinical development of new drug entities for the treatment of seriously debilitating disorders. Learn more here: aimimmuno.com
#pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Happening Today: We will be presenting in the 2023 Virtual Investor Companies to Watch Event today at 11:00 AM ET. Register here: us02web.zoom.us/webinar/register/WN_k3GOjPkJRCGa_bOi_SLfwA
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Enters into Pancreatic Cancer Clinical Research Agreements with AstraZeneca and Erasmus Medical Center.
aimimmuno.com/press-release/aim-immunotech-enters-into-pa…
#pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Take a look through our pipeline here: aimimmuno.com/pipeline/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Stay up to date on all things AIM by signing up for our email alerts.
aimimmuno.com/email-alerts/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Broadens Patent Portfolio with New Netherlands Utility Patent Covering Ampligen® and Other AIM-Developed dsRNA Products to Include Rugged dsRNA for Use in COVID-19 Treatment or Prevention
aimimmuno.com/press-release/aim-immunotech-broadens-paten… -
AIM ImmunoTech
@AimImmuno
This year posed challenges for many. As we reflect on 2022, these three words come to mind: perseverance, dedication, resilience.
#pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Best wishes for a joyous holiday season!
-
AIM ImmunoTech
@AimImmuno
2022 Highlight Series: Announced FDA clearance of IND application to evaluate lead product candidate in Phase 2 clinical study for the treatment of post-COVID conditions in October 2022.
aimimmuno.com/press-release/aim-immunotech-announces-fda-…
#longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
2022 Highlight Series: Announced commencement of Phase 2 study of our lead product candidate for the treatment of pancreatic cancer in August.
aimimmuno.com/press-release/aim-immunotech-announces-comm…
#pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
2022 Highlight Series: Presentations and participation at many events throughout 2022.
aimimmuno.com/press-releases/
#pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
2022 Highlight Series: Reported additional patient data from single-center named patient program evaluating our lead product candidate as maintenance therapy for advanced pancreatic cancer in July 2022.
aimimmuno.com/press-release/aim-immunotech-reports-additi…
$AIM #pancreaticcancer #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Appoints Christopher McAleer, Ph.D. as Scientific Officer.
aimimmuno.com/press-release/aim-immunotech-appoints-chris…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
2022 Highlight Series: Reported positive pilot study data from expanded access program evaluating our lead product candidate for the treatment of long COVID in July.
aimimmuno.com/press-release/aim-immunotech-reports-positi…
$AIM #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
2022 Highlight Series: AIM ImmunoTech secured new state-of-the-art facility for product development and testing in June 2022.
aimimmuno.com/press-releases/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Stay up to date on all things AIM by signing up for our email alerts.
aimimmuno.com/email-alerts/
#pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Reports Positive Safety, Tolerability and Biological Activity Data for Intranasal Ampligen® (Rintatolimod) in Healthy Subjects
aimimmuno.com/press-release/aim-immunotech-reports-positi…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Dr. Peterson describes what a successful outcome from our Phase 2 study would look like from his perspective. Access the event replay here: us02web.zoom.us/webinar/register/WN_MI5W0hfkR4CXy5JyMu2tdw
$AIM @InvestorVirtual #virtualinvestor #longcovid #covid19 -
AIM ImmunoTech
@AimImmuno
Long COVID described by Dr. Lapp. Access the event replay here: us02web.zoom.us/webinar/register/WN_MI5W0hfkR4CXy5JyMu2tdw
$AIM @InvestorVirtual #virtualinvestor #longcovid #covid19 -
AIM ImmunoTech
@AimImmuno
Wishing you all a Happy Thanksgiving! $AIM
-
AIM ImmunoTech
@AimImmuno
Our CEO, Thomas Equels, M.S. J.D., touches on Long COVID and vaccines. Access the event replay here: us02web.zoom.us/webinar/register/WN_MI5W0hfkR4CXy5JyMu2tdw
@InvestorVirtual $AIM #virtualinvestor #longcovid #covid19 -
AIM ImmunoTech
@AimImmuno
Our CEO, Thomas Equels, M.S. J.D., gives a corporate overview of AIM. Access the event replay here: us02web.zoom.us/webinar/register/WN_MI5W0hfkR4CXy5JyMu2tdw
#virtualinvestor #longcovid #covid19This media couldn't be displayed. See it on the original post. -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech is engaged in the clinical development of new drug entities for the treatment of seriously debilitating disorders.
aimimmuno.com
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Reports Third Quarter 2022 Financial Results and Provides Corporate Update.
aimimmuno.com/press-release/aim-immunotech-reports-third-…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
$AIM ImmunoTech Announces Presentation of New Data from Roswell Park Comprehensive Cancer Center Evaluating Ampligen as a Component of a Chemokine-Modulating (CKM) Regimen, with Paclitaxel, for the Treatment of Early-Stage Triple Negative Breast Cancer.
aimimmuno.com/press-release/aim-immunotech-announces-pres… -
AIM ImmunoTech
@AimImmuno
Check out the mechanism behind our program in Long COVID explained by Dr. Peterson. Access the event replay here: us02web.zoom.us/webinar/register/WN_MI5W0hfkR4CXy5JyMu2tdw
$AIM @InvestorVirtual #virtualinvestor #longcovid #covid19 -
AIM ImmunoTech
@AimImmuno
Stay up to date on all things AIM by signing up for our email alerts.
aimimmuno.com/email-alerts/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Corporate Governance Enhancements.
aimimmuno.com/press-release/aim-immunotech-announces-corp…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Our CEO, Thomas Equels, M.S. J.D., highlights some of our potential upcoming milestones. Access the event replay here: us02web.zoom.us/webinar/register/WN_MI5W0hfkR4CXy5JyMu2tdw
@InvestorVirtual #virtualinvestor #longcovid #covid19 -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Shareholders Elect All Three Company Director Nominees at 2022 Annual Meeting.
aimimmuno.com/press-release/aim-immunotech-shareholders-e…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Receives Orphan Drug Designation for Ampligen (rintatolimod) for the Treatment of Ebola Virus Disease.
aimimmuno.com/press-release/aim-immunotech-receives-orpha…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Delaware Court Rules in Favor of AIM ImmunoTech and Declines to Declare Activist Group’s Nominations Valid.
aimimmuno.com/press-release/delaware-court-rules-in-favor… $AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
As October comes to an end, learn how you can get involved to provide help and hope to women fighting #breastcancer. Click here to join the cause: www.nationalbreastcancer.org/breast-cancer-support/
$AIM #savethetatas -
AIM ImmunoTech
@AimImmuno
Did you know when #breastcancer is detected early, and is in the localized stage, the 5-year relative survival rate is 99%? For additional information, click here: www.nationalbreastcancer.org/early-detection-of-breast-ca…
$AIM #savethetatas -
AIM ImmunoTech
@AimImmuno
Sign up for our email alerts to receive the most up-to-date news and alerts!
aimimmuno.com/email-alerts/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Have you or somebody you know been recently diagnosed with Metastatic #breastcancer? Find resources and support here: www.domain.com/resources/
@MBCNbuzz $AIM #savethetatas -
AIM ImmunoTech
@AimImmuno
Did you know today is National Metastatic #breastcancerawareness Day? Learn how you can get involved at www.domain.com/october-13-national-metastatic-breast-canc…
@MBCNbuzz $AIM #savethetatas -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces FDA Clearance of IND Application to Evaluate Ampligen in Phase 2 Clinical Study for the Treatment of Post-COVID Conditions.
aimimmuno.com/press-release/aim-immunotech-announces-fda-…
$AIM #longcovid #postcovid -
AIM ImmunoTech
@AimImmuno
Did you miss our recent presentation at the Virtual Investor Long COVID Event? Click here to watch the webcast replay: us02web.zoom.us/webinar/register/WN_MI5W0hfkR4CXy5JyMu2tdw
$AIM @InvestorVirtual -
AIM ImmunoTech
@AimImmuno
October is National #breastcancerawareness Month. To learn more about the disease visit www.nationalbreastcancer.org/about-breast-cancer/ for additional details.
@NBCF $AIM #savethetatas -
AIM ImmunoTech
@AimImmuno
We have been busy participating in several events the last few weeks. Check out our recent presentations here: aimimmuno.com/events-presentations/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Did you know October is National #breastcancerawareness Month? Learn more how you can get involved or contribute at www.nationalbreastcancer.org/breast-cancer-awareness-month/
@NBCF $AIM #breastcancer #savethetatas -
AIM ImmunoTech
@AimImmuno
Did you miss our recent presentation at the Virtual Investor Long COVID Event? Access the webcast replay here: us02web.zoom.us/webinar/register/WN_MI5W0hfkR4CXy5JyMu2tdw
@InvestorVirtual #virtualinvestor $AIM #longcovid #covid19 -
AIM ImmunoTech
@AimImmuno
We are presenting at the Virtual Investor Long COVID Event today at 3:00 PM ET! Tune in here to access the event: us02web.zoom.us/webinar/register/WN_MI5W0hfkR4CXy5JyMu2tdw
@InvestorVirtual #virtualinvestor $AIM #longcovid #covid19 -
AIM ImmunoTech
@AimImmuno
Be sure to tune in tomorrow! We are presenting at the Virtual Investor Long COVID Event at 3:00 PM ET. Access the event here: us02web.zoom.us/webinar/register/WN_MI5W0hfkR4CXy5JyMu2tdw
@InvestorVirtual #virtualinvestor $AIM #longcovid #covid19 -
AIM ImmunoTech
@AimImmuno
Immunology for a Better Future. aimimmuno.com
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Professor Casper van Eijck explains the design of our Phase 2 clinical trial. Click here to watch the full presentation: us02web.zoom.us/webinar/register/WN_Dv4OoWXzQsq5VY6QPDqv5A
@InvestorVirtual #virtualinvestor $AIM #pancreaticcancer -
AIM ImmunoTech
@AimImmuno
Mark your calendar! We are presenting at the Virtual Investor Long COVID Event on Wednesday, September 28th at 3:00 PM ET. Be sure to tune in! Access the event here: us02web.zoom.us/webinar/register/WN_MI5W0hfkR4CXy5JyMu2tdw
@InvestorVirtual #virtualinvestor $AIM #longcovid -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech to Present at the Virtual Investor Long COVID Event
aimimmuno.com/press-release/aim-immunotech-to-present-at-…
@InvestorVirtual #virtualinvestor $AIM #longcovid -
AIM ImmunoTech
@AimImmuno
Did you know that nearly 22,000 women in the United States are diagnosed with #ovariancancer each year, and approximately 14,000 women die from the disease? Learn more at ovarian.org/about-nocc/mission-and-vision/
@NOCC_National -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Board Files Definitive Proxy Statement and Sends Letter to Shareholders
aimimmuno.com/press-release/aim-immunotech-board-files-de…
$AIM -
AIM ImmunoTech
@AimImmuno
Did you miss our recent presentation at the H.C. Wainwright 24th Annual Global Investment Conference? Access the webcast replay here: journey.ct.events/view/9659f951-dcf9-4e65-bbb4-4f6bc531a46b
@HCWCO $AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Want to get involved with the National Ovarian Cancer Coalition? Click here for opportunities such as volunteering, fundraising and community events: ovarian.org/get-involved/
@NOCC_National -
AIM ImmunoTech
@AimImmuno
Did you know it is estimated that 1 in 78 women will develop #ovariancancer, and there are 0 screening tests for the disease? Learn more at ovarian.org
@NOCC_National -
AIM ImmunoTech
@AimImmuno
Our presentation at the H.C. Wainwright 24th Annual Global Investment Conference is now available. Access the webcast here: journey.ct.events/view/9659f951-dcf9-4e65-bbb4-4f6bc531a46b
@HCWCO $AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
We are attending the American Association for Cancer Research Special Conference: Pancreatic Cancer. Learn more here: www.aacr.org/meeting/aacr-special-conference-pancreatic-c…
@AACR $AIM #pancreaticcancer -
AIM ImmunoTech
@AimImmuno
Learn about how #prostatecancer is diagnosed, screenings and the statistics of detecting the disease early. Learn more at zerocancer.org/about-prostate-cancer
@ZEROCancer -
AIM ImmunoTech
@AimImmuno
We are proud to announce our sponsorship for this year’s 2nd Annual Marie Sklodowska-Curie Symposium on Cancer Research and Care and look forward to presenting at the event. Learn more here: www.roswellpark.org/msc-symposium
@RoswellPark $AIM -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech to Present at the H.C. Wainwright 24th Annual Global Investment Conference
aimimmuno.com/press-release/aim-immunotech-to-present-at-…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Selected to Present at the 2nd Annual Marie Sklodowska-Curie Symposium on Cancer Research and Care
aimimmuno.com/press-release/aim-immunotech-selected-to-pr…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
September is Prostate Cancer Awareness Month. Learn how you can get involved here: zerocancer.org
@ZEROCancer -
AIM ImmunoTech
@AimImmuno
Did you know September is Ovarian Cancer Awareness Month? To learn more about the disease visit ovarian.org.
@NOCC_National -
AIM ImmunoTech
@AimImmuno
Professor Casper van Eijck highlights the significance of maintenance therapy and what it means to those suffering from #pancreaticcancer. Listen in to learn more: us02web.zoom.us/webinar/register/WN_Dv4OoWXzQsq5VY6QPDqv5A
$AIM -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech and Study Collaborator Roswell Park Commence Enrollment in an NCI-funded Phase 2 Clinical Trial Evaluating Ampligen® (rintatolimod) in Primary PD-1/PD-L1 Resistant Melanoma
aimimmuno.com/press-release/aim-immunotech-and-study-coll…
@RoswellPark $AIM #melanoma #clinicaltrial -
AIM ImmunoTech
@AimImmuno
We recently welcomed Chris McAleer, Ph.D. to our team as Deputy Chief Science Officer! Tune in to hear his impressive background: us02web.zoom.us/webinar/register/WN_Dv4OoWXzQsq5VY6QPDqv5A
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Our CEO, Thomas Equels summarizes the Company and its key lead asset. Listen in to learn more: us02web.zoom.us/webinar/register/WN_Dv4OoWXzQsq5VY6QPDqv5A
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Commencement of Phase 2 Study of Ampligen® for the Treatment of Pancreatic Cancer
aimimmuno.com/press-release/aim-immunotech-announces-comm…
$AIM #pancreaticcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Reports Second Quarter 2022 Financial Results and Provides Corporate Update.
aimimmuno.com/press-release/aim-immunotech-reports-second…
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
It is our goal to provide you with the highest quality of information. Sign up for our email alerts here: aimimmuno.com/email-alerts/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Immunology For A Better Future – We are focused on advancing therapeutic candidates for multiple types of #cancers and immune-deficiency disorders. Learn more at aimimmuno.com/company/
$AIM #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer #longcovid #mecfs -
AIM ImmunoTech
@AimImmuno
Did you see our presentation from the Virtual Investor Innovations in Oncology Spotlight event? Check it out here: us02web.zoom.us/webinar/register/WN_Dv4OoWXzQsq5VY6QPDqv5A
$AIM #virtualinvestor #pancreaticcancer #ovariancancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Reports Positive Pilot Study Data from Expanded Access Program Evaluating Ampligen® for the Treatment of Long COVID
aimimmuno.com/press-release/aim-immunotech-reports-positi…
$AIM #longcovid -
AIM ImmunoTech
@AimImmuno
Did you miss our recent presentation at the JTC Virtual Investor Innovation in Oncology Spotlight Series? Access the webcast replay here: us02web.zoom.us/webinar/register/WN_Dv4OoWXzQsq5VY6QPDqv5A
$AIM @InvestorVirtual #virtualinvestor #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
We are participating in the JTC Virtual Investor Innovation in Oncology Spotlight Series today at 8:30 AM ET! Be sure to tune in here: us02web.zoom.us/webinar/register/WN_Dv4OoWXzQsq5VY6QPDqv5A
$AIM @InvestorVirtual #virtualinvestor #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
Be sure to tune in! We are presenting on Monday, July 25 at 8:30 AM ET at the JTC Virtual Investor Innovation in Oncology Spotlight Series. Learn more here: us02web.zoom.us/webinar/register/WN_Dv4OoWXzQsq5VY6QPDqv5A
$AIM @InvestorVirtual #virtualinvestor #ovariancancer #pancreaticcancer #breastcancer -
AIM ImmunoTech
@AimImmuno
$AIM ImmunoTech reports additional patient data from Single-Center Named Patient Program evaluating Ampligen as maintenance therapy for advanced #pancreaticcancer indicating additional progression-free and overall survival over previously published data.
aimimmuno.com/press-release/aim-immunotech-reports-additi… -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces that Recently Received Director Nominations from Jorgl Activist Group are Invalid.
aimimmuno.com/press-release/aim-immunotech-announces-that…
$AIM #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
#markyourcalendars! We are participating in the JTC Virtual Investor Innovation in Oncology Spotlight Series on July 25 at 8:30AM ET. Learn more here: virtualinvestorco.com
$AIM @InvestorVirtual #virtualinvestor #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
We are focused on the research and development of therapeutics to treat multiple types of cancers, as well as immune-deficiency disorders. Learn more at aimimmuno.com/company/
$AIM #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech to Present at the Virtual Investor Innovations in Oncology Spotlight Series
aimimmuno.com/press-release/aim-immunotech-to-present-at-…
$AIM #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer #virtualinvestor @InvestorVirtual -
AIM ImmunoTech
@AimImmuno
Interested in AIM ImmunoTech? Learn more by viewing our Company Presentation here: aimimmuno.com/events-presentations/
$AIM #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
Be sure to sign up for our email alerts to stay updated on all announcements! aimimmuno.com/email-alerts/
$AIM #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
We are engaged in the clinical development of new drug entities for the treatment of seriously debilitating disorders. Learn more at aimimmuno.com
$AIM #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
Freedom rings true under the red, white and blue. We wish everyone a very happy and safe Fourth of July!
-
AIM ImmunoTech
@AimImmuno
Have you seen our most recent company presentation? Check it out here: d2ghdaxqb194v2.cloudfront.net/2265/186712.pdf
$AIM #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Secures New State-of-the-Art Facility for Product Development and Testing
aimimmuno.com/press-release/aim-immunotech-secures-new-st…
$AIM #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
Sign up for our email alerts to get the most recent news updates!
aimimmuno.com/email-alerts/
$AIM #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Bolsters Intellectual Property Portfolio for Ampligen® with Issuance of New Netherlands Utility Patent Covering Ampligen® and other AIM Developed dsRNA Products for Use in COVID-19 Treatment or Prevention
aimimmuno.com/press-release/aim-immunotech-bolsters-intel…
$AIM #longcovid -
AIM ImmunoTech
@AimImmuno
We are focused on the research and development of therapeutics to treat multiple types of cancers, as well as immune-deficiency disorders.
$AIM #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
Did you know yesterday was National Cancer Survivors Day? A day we celebrate those who have survived their battle against cancer! They are a true inspiration for all recently diagnosed. Learn how to get involved here: ncsd.org
@SurvivorsDay -
AIM ImmunoTech
@AimImmuno
We presented at the H.C. Wainwright Global Investment Conference. Check out the webcast replay at: journey.ct.events/view/95e638c1-d6d8-4a88-9225-873a65968f9b
$AIM #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
This Memorial Day Weekend we remember and honor all who served in our armed forces.
-
AIM ImmunoTech
@AimImmuno
Our presentation at the H.C. Wainwright Global Investment Conference is now available at: journey.ct.events/view/95e638c1-d6d8-4a88-9225-873a65968f9b
$AIM #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
We will be participating in the upcoming H.C. Wainwright Global Investment Conference. To learn more, visit: journey.ct.events/view/95e638c1-d6d8-4a88-9225-873a65968f9b
$AIM #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech to Present at the H.C. Wainwright Global Investment Conference
aimimmuno.com/press-release/aim-immunotech-to-present-at-…
$AIM #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Provides Update on Ampligen Long COVID Development Program
aimimmuno.com/press-release/aim-immunotech-provides-updat…
$AIM #myalgicencephalomyelitis #chronicfatiguesyndrome #longcovid -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Reports First Quarter 2022 Financial Results and Provides Corporate Update
aimimmuno.com/press-release/aim-immunotech-reports-first-…
$AIM #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer #leadership #managementteam -
AIM ImmunoTech
@AimImmuno
We believe there is a critical unmet need for additional therapies to expand treatment options for cancer.
aimimmuno.com/pipeline/
$AIM #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech to Participate in a Solve M.E. Signature Event: ‘Long COVID: Research, Policy, and Economic Impact’ on May 19, 2022
aimimmuno.com/press-release/aim-immunotech-to-participate…
$AIM #myalgicencephalomyelitis #chronicfatiguesyndrome #longcovid @PlzSolveCFS -
AIM ImmunoTech
@AimImmuno
We believe the key to a strong foundation is an experienced leadership team. Meet our team at aimimmuno.com/company/
$AIM #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer #leadership #managementteam -
AIM ImmunoTech
@AimImmuno
It is our goal to keep all key stakeholders up to date with the latest information. Sign up for our email alerts to stay up-to-date!
aimimmuno.com/email-alerts/
$AIM #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
We are engaged in the clinical development of new drug entities for the treatment of seriously debilitating disorders. Learn more at aimimmuno.com
$AIM #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
Our lead program, Ampligen®, is poised for potential value creation.
$AIM #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
We are an immuno-pharma company with a broad pipeline and significant opportunity across multiple disease areas of large unmet need.
$AIM #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech reposted
Proactive USA
@proactive_NA
$AIM AIM ImmunoTech says Ampligen data supports synergistic potential with checkpoint blockade therapies www.proactiveinvestors.com/companies/news/980445/aim-immu… @AimImmuno #aim
-
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech is backed by a proven management team. Learn more about us here: aimimmuno.com/company/
$AIM #meettheteam #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Provides Summary of Ampligen® Data Supporting Synergistic Potential with Checkpoint Blockade Therapies
aimimmuno.com/press-release/aim-immunotech-provides-summa…
$AIM #pancreaticcancer #oncology -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Provides Progress on Advancement of Ampligen® Clinical Development Program for the Treatment of Pancreatic Cancer
aimimmuno.com/press-release/aim-immunotech-provides-progr…
#pancreaticcancer #oncology -
AIM ImmunoTech
@AimImmuno
Join our email list to stay up to date on our recent news, presentations and filings! Sign up here: aimimmuno.com/email-alerts/
$AIM -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Positive Data from Phase 2a Study Evaluating Ampligen® as a Component of a Chemokine Modulatory (CKM) Regimen for the Treatment of Colorectal Cancer Metastatic to the Liver
aimimmuno.com/press-release/aim-immunotech-announces-posi…
$AIM #colorectalcancer #oncology -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Positive Data from Phase 1 Study Evaluating Ampligen® for the Treatment of Stage 4 Metastatic Triple Negative Breast Cancer
aimimmuno.com/press-release/aim-immunotech-announces-posi…
$AIM #breastcancer #oncology -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update.
aimimmuno.com/press-release/aim-immunotech-reports-fourth…
$AIM #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Abstract Accepted for Presentation at 15th Annual IHPBA World Congress.
aimimmuno.com/press-release/aim-immunotech-announces-abst…
$AIM #ihpba22 -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Abstract Accepted for Poster Presentation by Roswell Park Comprehensive Cancer Center at the AACR 2022 Annual Meeting.
aimimmuno.com/press-release/aim-immunotech-announces-abst…
$AIM #aacr2022 #aacr22 -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest.
aimimmuno.com/press-release/aim-immunotech-to-participate… $AIM -
AIM ImmunoTech
@AimImmuno
It’s #colorectalcancerawarenessmonth! Don’t forget to access life-saving resources to prevent, detect, and treat #colorectalcancer here: colorectalcancer.org/screening-quiz
$AIM @CCAlliance #tomorrowcantwait #coloncancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Receives IND Clearance from the U.S. FDA to Advance its Phase 2 Study of Ampligen® for the Treatment of Locally Advanced Pancreatic Cancer.
aimimmuno.com/press-release/aim-immunotech-receives-ind-c…
$MBRX #pancreaticcancer #oncology -
AIM ImmunoTech
@AimImmuno
Have you had a chance to flip through our new corporate presentation? Check it out here: aimimmuno.com/events-presentations/
$AIM #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
We look forward to the further evaluation of Ampligen to unlock its full potential. Check our recent publication in @MDPIOpenAccess at www.mdpi.com/2072-6694/14/6/1377
$AIM #oncology -
AIM ImmunoTech
@AimImmuno
Sign up for email alerts to stay up to date on our latest news!
aimimmuno.com/email-alerts/
$AIM #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Abstract from University of Pittsburgh Medical Center Accepted for Presentation at the AACR 2022 Annual Meeting.
aimimmuno.com/press-release/aim-immunotech-announces-abst…
$AIM #ovariancancer #oncology -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Abstracts from Roswell Park Comprehensive Cancer Center Accepted for Presentation in a Late-Breaking Poster Session at the AACR 2022 Annual Meeting.
aimimmuno.com/press-release/aim-immunotech-announces-abst…
$AIM #breastcancer #colorectalcancer #oncology -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Publication of Positive Data from Late-Stage Pancreatic Cancer Early Access Program (EAP) in the Cancers Special Issue: Combination and Innovative Therapies for Pancreatic Cancer.
aimimmuno.com/press-release/aim-immunotech-announces-publ…
$AIM @Cancers_MDPI #pancreaticcancer #oncology -
AIM ImmunoTech
@AimImmuno
$AIM ImmunoTech is an immuno-pharma company focused on the development of therapeutics to treat multiple types of cancers, viral diseases and immune-deficiency disorders. Learn more here: aimimmuno.com
#ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Strategic Sale of New Brunswick, New Jersey Facility to Allocate Additional Resources to Advance Pipeline.
aimimmuno.com/press-release/aim-immunotech-announces-stra…
$AIM -
AIM ImmunoTech
@AimImmuno
In recognition of #colorectalcancerawarenessmonth, we encourage you to dress in blue tomorrow, March 4th, to support the many #colorectalcancer patients and survivors. Learn more here: colorectalcancer.org/get-involved/advocate/colorectal-can…
$AIM @CCAlliance #tomorrowcantwait #coloncancer -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Appoints Robert Dickey, IV as Chief Financial Officer.
aimimmuno.com/press-release/aim-immunotech-appoints-rober…
$AIM -
AIM ImmunoTech
@AimImmuno
March is #colorectalcancerawarenessmonth! We welcome you to join the @CCAlliance in sharing their programs for #colorectalcancer screening, care and cure. Learn more here: colorectalcancer.org/get-involved/advocate/colorectal-can…
$AIM #tomorrowcantwait #coloncancer -
AIM ImmunoTech
@AimImmuno
#didyouknow that 16.9 million U.S. cancer patients are living with, through and beyond their disease? Learn more about the impact #cancerresearch has had on the patient and medical community here: cancerprogressreport.aacr.org/progress/cpr21-contents/cpr…
$AIM @AACRFoundation #nationalcancerpreventionmonth -
AIM ImmunoTech
@AimImmuno
Sign up for email alerts to stay up to date on our latest news! aimimmuno.com/email-alerts/
$AIM #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
We are an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, as well as immune-deficiency disorders. Learn more about our developments here: aimimmuno.com
$AIM #nationalcancerpreventionmonth -
AIM ImmunoTech
@AimImmuno
Achieving a healthier lifestyle can be done impactfully through small but meaningful actions. Learn more about the #worldcancerday 21 Days to Impact Challenge www.worldcancerday.org/21DayChallenge.
#nationalcancerpreventionmonth -
AIM ImmunoTech
@AimImmuno
Did you see our presentation at the Virtual Investor 2022 Top Picks Conference? Check it out here: us02web.zoom.us/webinar/register/WN___sVPlXmToOnKaT_MLV7Ig.
$AIM @InvestorVirtual #virtualinvestor #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
The Covid Vaccine We Need Now May Not Be a Shot www.nytimes.com/2022/02/02/health/covid-vaccine-nasal.html
-
AIM ImmunoTech
@AimImmuno
#didyouknow February is #nationalcancerpreventionmonth? Join the American Association for Cancer Research building awareness. Learn more here: www.aacr.org/patients-caregivers/awareness-months/nationa…
@AACRFoundation #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer -
AIM ImmunoTech
@AimImmuno
We encourage you to be a part of #worldcancerday. Learn how you can take action here: www.worldcancerday.org
#closethecaregap #ovariancancer #pancreaticcancer #breastcancer #colorectalcancer #nationalcancerpreventionmonth -
AIM ImmunoTech reposted
Solve ME/CFS Initiative
@PlzSolveCFS
Solve M.E. is excited to host leaders from @AimImmuno and for "Ampligen: A General Overview and the Plan for ME/CFS & Long Covid" on Jan 27, 2022 at 11am PT. We will also be joined by two doctors experienced with Ampligen treatment. Register here: us02web.zoom.us/webinar/register/WN_rK1p0L4fTlyCZ2paSBoSZQ
-
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech to Participate in Solve M.E. Diagnostics and Treatments Webinar on Thursday, January 27th at 2:00 pm ET.
Access the event at us02web.zoom.us/webinar/register/WN_rK1p0L4fTlyCZ2paSBoSZQ
$AIM @PlzSolveCFS #myalgicencephalomyelitis #chronicfatiguesyndrome #longcovid -
AIM ImmunoTech
@AimImmuno
Phase 1 trial combining chemokine targeting with loco regional chemo immunotherapy for recurrent, platinum sensitive ovarian cancer shows induction of CXCR3 ligands and markers of type 1 immunity.
aacrjournals.org/clincancerres/article/28/10/2038/694832/…
$AIM @AACR #ovariancancer#Publication -
AIM ImmunoTech
@AimImmuno
We continue to be encouraged by the data being generated and look forward to the continued advancement of Ampligen®.
aimimmuno.com/press-release/aim-immunotech-announces-publ…
$AIM #ovariancancer #publication -
AIM ImmunoTech
@AimImmuno
We are excited by the potential of our lead program, Ampligen®.
aimimmuno.com/press-release/aim-immunotech-announces-publ…
$AIM #ovariancancer #publication -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Publication of Positive Results from Phase 1/2 Study of Intraperitoneal Chemo Immunotherapy in Advanced Recurrent Ovarian Cancer.
aimimmuno.com/press-release/aim-immunotech-announces-publ…
@AACR $AIM #ovariancancer #publication -
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech to Present at the Virtual Investor 2022 Top Picks Conference
aimimmuno.com/press-release/aim-immunotech-to-present-at-…
$AIM @InvestorVirtual #virtualinvestor #savethedate -
AIM ImmunoTech
@AimImmuno
$AIM is pleased to announce our engagement with @jtc_team to provide strategic #investorrelations advisory services. This collaboration represents a key component in our overall corporate strategy to keep current investors up-to-date and build awareness with new audiences.
-
AIM ImmunoTech
@AimImmuno
$AIM announced safety data on its drug #ampligen was presented at the 8th European Scientific Working Group on #influenza (ESWI) virtual conference in Salzburg, Austria Dec 4-7. Conference also included research on #covid19 and respiratory syncytial virus: aimimmuno.com/press-release/aim-immunotechs-ampligen-safe…
-
AIM ImmunoTech
@AimImmuno
$AIM today announced that Thomas Equels, Chief Executive Officer, will be participating in two upcoming investor conferences: aimimmuno.com/press-release/aim-immunotech-ceo-to-partici… @BioFlorida #biofl2021 @Benzinga
-
AIM ImmunoTech
@AimImmuno
$AIM recently announced financial results for the third quarter ended September 30, 2021 and provided a business update: aimimmuno.com/press-release/aim-immunotech-provides-third… @aimimmuno
#aimimmuno #biotech #pharmaceutical #mecfs #cancerresearch #stocks #clinicaltrials -
AIM ImmunoTech
@AimImmuno
$AIM announced it has submitted an Investigational New Drug application and an accompanying application for Fast Track status with the #fda for a planned Phase2 study of #ampligen as a therapy for locally advanced or metastatic late-stage #pancreaticcancer aimimmuno.com/press-release/aim-immunotech-submits-ind-an…
-
AIM ImmunoTech
@AimImmuno
$AIM today released detailed safety data from a Phase 1 #clinicalstudy that supports the company’s belief that its drug #ampligen has significant potential as an intranasal therapeutic for #covid19: aimimmuno.com/press-release/aim-immunotech-publishes-phas… #biotech #pharmaceuticals #medicine #longcovid
-
AIM ImmunoTech
@AimImmuno
$AIM today announced that it has finalized the protocol for a planned Phase 2 study of the company’s drug #ampligen as a therapy for locally advanced or metastatic late-stage #pancreaticcancer. aimimmuno.com/press-release/aim-immunotech-provides-clini…
-
AIM ImmunoTech
@AimImmuno
$AIM and $hVIVO have a signed Clinical Trial Agreement for a Phase 2a Human Challenge Trial to test the company’s drug #ampligen as a potential intranasal prophylactic using a human #rhinovirus (HRV-16, a common cold virus) and #influenza A virus (H3N2): aimimmuno.com/press-release/aim-immunotech-announces-clin…
-
AIM ImmunoTech
@AimImmuno
$AIM has submitted a Pre-Investigational New Drug application to the #fda for 2 separate Phase 2 clinical studies to study the potential of #ampligen as both an infusion and an intranasal therapy for early-onset #covid19, the disease caused by SARS-CoV-2.
aimimmuno.com/press-release/aim-immunotech-submits-pre-in… -
AIM ImmunoTech
@AimImmuno
$AIM files provisional #patent application for #ampligen as an early-onset intranasal therapy that may also confer enhanced immunity to a wide range of respiratory viruses: aimimmuno.com/press-release/aim-immunotech-files-provisio… #mecfs #covid19 #longcovid #biotech #pharmaceutical
-
AIM ImmunoTech
@AimImmuno
New York Times - "This is really scary:" Kid Struggle with Long COVID #longcovid #covid19 #mecfs www.nytimes.com/2021/08/08/health/long-covid-kids.html
-
AIM ImmunoTech
@AimImmuno
$AIM announced positive progress with the company’s meeting request to the #fda concerning Phase2 #clinicalstudy of #ampligen as an infusion therapy for Post-#covid19 Cognitive Dysfunction #pccd aimimmuno.com/press-release/aim-immunotech-announces-posi… #biotech #pharma #longcovid #mecfs
-
AIM ImmunoTech
@AimImmuno
$AIM provided a status update on its Phase 2a Human Challenge Trial to test its drug #ampligen as a potential intranasal prophylactic therapy using human rhinovirus (HRV-16) and influenza A virus (H3N2) aimimmuno.com/press-release/aim-immunotech-provides-an-up… #biotech #pharmaceutical #covid19 #mecfs #longcovid
-
AIM ImmunoTech
@AimImmuno
$AIM has submitted a Pre-Investigational New Drug Application (Pre-IND) to the #fda for a Phase 2 #clinicalstudy of #ampligen as a potential infusion therapy for Post #covid19 Cognitive Dysfunction #pccd aimimmuno.com/press-release/aim-immunotech-submits-pre-in… #pharmaceutical #biotech #longcovid #medicine
-
AIM ImmunoTech
@AimImmuno
$AIM ImmunoTech announces filing of Provisional #patent Application for use of #ampligen as both an Intranasal and an IV Therapy for Post-#covid19 Cognitive Dysfunction #pccd: aimimmuno.com/press-release/aim-immunotech-announces-fili… #pharmaceutical #healthcare #biotech
-
AIM ImmunoTech reposted
Proactive USA
@proactive_NA
$AIM AIM ImmunoTech is well positioned with $57.3M to execute on its corporate strategy and advance clinical trials www.proactiveinvestors.com/companies/news/957946/aim-immu… @AimImmuno #aim
-
AIM ImmunoTech
@AimImmuno
#aimimmunotech announces financial results for the second quarter ended June 30, 2021 and provides a business update aimimmuno.com/press-release/aim-immunotech-provides-secon… #biotech #pharmaceutical #covid19 #cancer #mecfs #immunooncology #ampligen #investors #medicalresearch #pancreaticcancer #immunology
-
AIM ImmunoTech
@AimImmuno
$AIM today announced that CEO Thomas K. Equels has been appointed to the Board of Directors of #bioflorida, the state’s life sciences industry association: aimimmuno.com/press-release/aim-ceo-thomas-k-equels-named…
-
AIM ImmunoTech
@AimImmuno
$AIM has signed a contract to sponsor a Phase 2a Human Challenge Trial (HCT) to test the company’s drug #ampligen as a potential intranasal antiviral therapy using a human #rhinovirus #hrv (common cold virus) and #influenza: aimimmuno.com/press-release/aim-immunotech-announces-phas… #biotechnology #pharmaceuticals
-
AIM ImmunoTech
@AimImmuno
‘I felt betrayed’: how Covid research could help patients living with chronic fatigue syndrome #mecfs #longcovid www.theguardian.com/australia-news/2021/jun/30/i-felt-bet…
-
AIM ImmunoTech reposted
Proactive USA
@proactive_NA
$AIM AIM ImmunoTech's Ampligen featured in medical journal Cancers, updates on Phase 1 study www.proactiveinvestors.com/companies/news/952990/aim-immu… @AimImmuno #aim
-
AIM ImmunoTech
@AimImmuno
$AIM announced that all subjects have completed treatment in the Phase 1 #clinicalstudy to assess the safety, tolerability and biological activity of #ampligen as a potential intranasal therapy. Final study report is expected in the third quarter of 2021: aimimmuno.com/press-release/aim-immunotech-completes-all-…
-
AIM ImmunoTech
@AimImmuno
$AIM is committed to supporting patients and families coping with #pancreaticcancer through ongoing and expanded research and clinical studies. www.radioiowa.com/2021/06/14/pancreative-cancer-survivors…
-
AIM ImmunoTech
@AimImmuno
$AIM today announced #ampligen has been featured in a publication containing state-of-the-art methodologies in peer-reviewed medical journal "Cancers" as a potential treatment option for #cancer patients who are infected with SARS-CoV-2; Patent granted: aimimmuno.com/press-release/aim-immunotechs-ampligen-feat…
-
AIM ImmunoTech
@AimImmuno
Johns Hopkins Medicine researchers find young people susceptible to #mecfs after #covid19 - this type of news stresses the importance of $AIM's research and clinical studies #longcovid: www.timesnownews.com/health/article/johns-hopkins-medicin…
-
AIM ImmunoTech
@AimImmuno
#mecfs is a perplexing disease with no known cause, but some evidence suggests it is due to an overactive immune system and can even be triggered by viral infection #longcovid shows many similarities, which is why researchers are keen to compare the two: www.sciencealert.com/covid-long-haulers-are-experiencing-…
-
AIM ImmunoTech
@AimImmuno
$AIM has entered into a two year extension of its Material Transfer and Research Agreement with Shenzhen Smoore Technology Limited with the goal of developing #ampligen as a potential inhalation therapy for #covid19 and other respiratory viral diseases: www.globenewswire.com/news-release/2021/05/27/2237467/294…
-
AIM ImmunoTech
@AimImmuno
$AIM has completed dosing of Cohort 3 in a Phase 1 #clinicalstudy to assess safety of #ampligen as an intranasal therapy, reporting no serious adverse events. It is consistent with previous results at escalating doses. #covid #mecfs aimimmuno.com/press-release/aim-immunotech-announces-posi…
-
AIM ImmunoTech
@AimImmuno
$AIM is dedicated to finding solutions for #longcovid and #mecfs as outlined in its 2021 First Quarter Business Update: aimimmuno.com/press-release/aim-immunotech-provides-first… @NPR @NPRHealth #covid19 #longhaulers news.wbfo.org/post/health-experts-put-more-focus-long-cov…
-
AIM ImmunoTech
@AimImmuno
$AIM ImmunoTech announces financial results for the first quarter ended March 31, 2021: aimimmuno.com/press-release/aim-immunotech-provides-first… Check the company's most recent presentations for updates on ongoing clinical studies: aimimmuno.com/events-presentations/
-
AIM ImmunoTech
@AimImmuno
$AIM CEO Thomas K. Equels participated in a Fireside Chat with Ed Woo of #ascendiant Capital. They discussed recent accomplishments, key goals and milestones, and AIM’s financial and operational outlook: aimimmuno.com/FiresideChat050321 #mecfs #longcovid #covid19 #biotech #pharma #cancer
-
AIM ImmunoTech
@AimImmuno
Jason Gale of #bloomberg writes, "the scale of the #pandemic means that #covid19's disabling effects — as well as the economic pain and drain on health resources — could persist well after the contagion ends." www.washingtonpost.com/business/why-impact-of-long-covid-…
-
AIM ImmunoTech
@AimImmuno
$AIM has completed dosing of Cohort 2 in a Phase 1 clinical study to assess the safety, tolerability and biological activity of #ampligen as an intranasal therapy for #covid19 and other respiratory illnesses, reporting no serious adverse events (SAE): aimimmuno.com/press-release/aim-immunotech-announces-posi…
-
AIM ImmunoTech
@AimImmuno
$AIM's presentation during the H.C. Wainwright Global Life Sciences Conference is now available online. CEO Thomas K. Equels shares updates on the latest research and development of therapeutics to treat #pancreaticcancer, #mecfs, and #covid19: #ampligen journey.ct.events/view/1c5ad409-008c-41c7-93c9-2897f2d2121f
-
AIM ImmunoTech
@AimImmuno
$AIM completed dosing of Cohort 1 in a Phase 1 clinical study on the safety of #ampligen as an intranasal therapy and reported no serious adverse events. A critical step in developing a potential treatment for #covid19 and other respiratory viral diseases. aimimmuno.com/press-release/aim-immunotech-announces-posi…
-
AIM ImmunoTech
@AimImmuno
$AIM posts financial results for fiscal year ended December 31, 2020. Company notes several significant milestones - including financial highlights, COVID-19 pandemic initiatives, and cancer clinical trial programs: aimimmuno.com/press-release/aim-immunotech-reports-2020-y…
-
AIM ImmunoTech
@AimImmuno
The Institutional Review Board at Roswell Park Comprehensive Cancer Center approved an amendment to the Phase 1/2a study evaluating the combination of #aim’s #ampligen and interferon alpha-2b as a potential treatment for patients with #cancer and #covid19: aimimmuno.com/press-release/aim-immunotech-announces-addi…
-
AIM ImmunoTech
@AimImmuno
$AIM CEO Thomas K. Equels will be presenting at the Q1 Virtual Investor Summit (formerly MicroCap Conference) on March 24 at 3:00 PM EST. More details: aimimmuno.irpass.com/ViewEmail.asp?b=2265&id=199865&p=219… #mecfs #pancreaticcancer #longcovid #longhaulers #biotechnology #pharmaceutical
-
AIM ImmunoTech
@AimImmuno
$AIM CEO Thomas K. Equels along with many other important voices in the #healthcare industry have been invited to present at the inaugural Emerging Growth Virtual #conference March 17-19: www.globenewswire.com/news-release/2021/03/10/2190241/0/e… #pharmaceuticals #biotech #mecfs #longcovid #covid19 #cancer
-
AIM ImmunoTech
@AimImmuno
#aim announced the first healthy subjects in Phase 1 #clinicalstudy of #ampligen as a potential intranasal therapy, which could be used to develop an internasal prophylaxis or early-stage treatment for #covid19 and other respiratory viral diseases: aimimmuno.com/press-release/aim-immunotech-announces-firs…
-
AIM ImmunoTech reposted
Solve ME/CFS Initiative
@PlzSolveCFS
Solve M.E. CEO Oved Amitay will present at the 2nd Interagency ME/CFS Working Group meeting hosted by @cdc & @NIH Feb. 25 & 26 (1PM ET). Topics include education of #mecfs healthcare providers & current activities to address #longcovid. Register here:
cdc.zoomgov.com/webinar/register/WN_E-Cd1WZSThuXBM5OqZdKCw -
AIM ImmunoTech
@AimImmuno
$AIM announced that its subsidiary, NV Hemispherx Biopharma Europe, has received notification from the European Commission approving Orphan Medicinal Product Application for #ampligen as a treatment for #pancreaticcancer aimimmuno.com/press-release/aim-immunotechs-subsidiary-re… #medical #pharma #biotech #cancer
-
AIM ImmunoTech
@AimImmuno
$AIM has received approval from the Ethics Committee in the Netherlands to start a clinical study on the safety of #ampligen as an intranasal therapy, a critical step to developing a potential treatment for #covid19 and other respiratory viral diseases: www.globenewswire.com/news-release/2021/02/16/2176319/0/e…
-
AIM ImmunoTech
@AimImmuno
$AIM announced Dutch Health and Youth Care Inspectorate has approved #rintatolimod #ampligen as a treatment for more #pancreaticcancer patients as part of a new Early Access Program #eap at Erasmus Medical Center www.globenewswire.com/news-release/2021/02/10/2173301/0/e… #oncology #biotechnology #pharmaceuticals
-
AIM ImmunoTech
@AimImmuno
$AIM has completed its At-The-Market #atm facility and closed the Equity Distribution Agreement. Management said AIM has adequate funds to meet anticipated operational cash needs and fund clinical trials for the next 24 months. #mecfs #longcovid #covid19
-
AIM ImmunoTech
@AimImmuno
$AIM announced that it has entered into a sponsorship agreement with the Centre for Human Drug Research #cdhr for the proposed #clinicalstudy of #ampligen as an intranasal therapy, a critical step in developing a #covid19 treatment: aimimmuno.com/press-release/aim-immunotech-enters-into-ag… #longcovid #longhaulers
-
AIM ImmunoTech
@AimImmuno
As $AIM works to develop a therapeutic for #covid19 patients with #chronicfatigue and enrollment continues for the AMP-511 Expanded Access Program #eap, @KDVR speaks with a #longhauler about her road to recovery: kdvr.com/news/coronavirus/22-year-old-covid-long-hauler-f… #ampligen #mecfs
-
AIM ImmunoTech
@AimImmuno
If you missed the January 21 investor conference call, click here to view the webcast: aimimmuno.com/events-presentations. $AIM is excited about our outlook for 2021! #mecfs #chronicfatigue #longhaulers #longcovid #cancer #covid19 #clincialtrials #medical #investments #stocks #oncology
-
AIM ImmunoTech
@AimImmuno
Final Reminder: $AIM will host an investor #conferencecall today at 11:00 am EST. CEO will discuss the latest #covid19 #mecfs and #cancer research and important achievements. For more details: aimimmuno.com/press-release/aim-immunotech-reschedules-in… #chronicfatigue #ampligen #investment #longcovid #longhaulers
-
AIM ImmunoTech
@AimImmuno
#wftv reports on $AIM potential treatment for #covid19 patients fighting #chronicfatigue #mecfs: www.wftv.com/unavailable-location/ AIM CEO to host #investor #conferencecall Jan 21 at 11:00 am to discuss these developments and recent achievements #longcovid #longhaulers #biotech #pharma
AIM ImmunoTech
@AimImmuno
-
AIM ImmunoTech
@AimImmuno
“We know this is real” @AP reports the emergence of #longcovid clinics focused on extended care for #longhauler patients: www.modernhealthcare.com/providers/we-know-this-real-new-…. $AIM will address #covid research and other achievements in #mecfs #cancer #ampligen during the Jan 21 conference call at 11:00 am.
AIM ImmunoTech
@AimImmuno
-
AIM ImmunoTech
@AimImmuno
#wkmg reports on the $AIM announcement that the company officially provided the first dose of its experimental drug #ampligen to a #longcovid patient with #mecfs symptoms. This new development to be discussed at Jan 21 #investor conference: www.clickorlando.com/news/local/2021/01/06/ocala-based-co…
#covid19 -
AIM ImmunoTech
@AimImmuno
$AIM has rescheduled the #investor conference call to Jan 21. Among the topics to be discussed is the recently announced commencement of the treatment of subjects with #covid19-induced #chronicfatigue-like symptoms in the amended AMP-511 trial: www.globenewswire.com/news-release/2021/01/15/2159268/0/e… #mecfs
-
AIM ImmunoTech
@AimImmuno
$AIM ImmunoTech has postponed the Investor Conference Call slated for January 12. The Company will reschedule for a later date: www.globenewswire.com/news-release/2021/01/11/2156080/0/e…
-
AIM ImmunoTech
@AimImmuno
$AIM to host an #investor conference call on Jan 12. Details below. Among the topics will be the prospects for #ampligen as a treatment for #longcovid, #mecfs, and #cancer as reported in the #wsj: www.wsj.com/articles/experimental-drugs-aim-to-treat-long… #longhaulers #medical #biotech #pharmaceutical #oncology
-
AIM ImmunoTech
@AimImmuno
$AIM announces first #covid19 induced Chronic Fatigue #mecfs #longhauler patient dosed with #ampligen. $AIM to host investor conference call on January 12 to discuss developments with AMP-511 trial and provide updates on other achievements and milestones: aimimmuno.com/press-release/aim-immunotech-announces-firs…
-
AIM ImmunoTech
@AimImmuno
#scientificamerican reports "The Problem of #longcovid" as more and more patients are dealing with major symptoms that linger for months. Article supports the effort to find solutions www.scientificamerican.com/article/the-problem-of-long-ha… #mecfs #biotech #covid19 #longhaulers #medical #medicine #pharmaceutical
-
AIM ImmunoTech
@AimImmuno
#provactive reports: $AIM green-lit by the #fda for its #clinicaltrials to treat #coronavirus patients with #cancer Watch interview: www.proactiveinvestors.com/companies/news/920194/aim-immu… #mecfs #covid19 #biotech #pharmaceutical #drug #medicine #medical #longhaulers #longcovid #ampligen #oncology
-
AIM ImmunoTech reposted
The New York Times
@nytimes
A small number of Covid patients who had never experienced mental health problems are developing severe psychotic symptoms weeks after contracting the coronavirus. Cases are expected to remain rare but are being reported worldwide. www.nytimes.com/2020/12/28/health/covid-psychosis-mental.…
-
AIM ImmunoTech
@AimImmuno
$AIM CEO discusses recent advancements in potential #coronavirus treatment #ampligen with @proactive_NA www.proactiveinvestors.com/companies/news/917100/aim-immu… #covidー19 #covid19 #mecfs #biotech #pharmaceutical #longcovid #longhaulers #drug #medical #medicine #clinicaltrials #pandemic
-
AIM ImmunoTech
@AimImmuno
While the Hartford Courant explores the ongoing struggles of #longcovid patients: www.courant.com/coronavirus/hc-news-coronavirus-covid-lon… while $AIM announces the availability of the #mecfs clinical trial of #ampligen for enrollment to #covid19 #longhaulers www.globenewswire.com/news-release/2020/12/24/2150498/0/e…
-
AIM ImmunoTech
@AimImmuno
$AIM announced today post #covid19 #longhauler portion of active AMP-511 #eap protocol has received authorization from the #irb for public notification of potential patient enrollment. Patients to be treated w/ pipeline drug #ampligen: www.globenewswire.com/news-release/2020/12/24/2150498/0/e… #mecfs #longcovid
-
AIM ImmunoTech
@AimImmuno
#healthline reports, “when it comes to long-haul #covid19, we may be facing another public health crisis." Recently, $AIM announced IRB approval to enroll #covid19 #longhaulers in the AMP-511 #mecfs clinical trial of #ampligen: finance.yahoo.com/news/aim-immunotech-announces-irb-appro… and www.healthline.com/health-news/what-we-know-about-long-co…
-
AIM ImmunoTech
@AimImmuno
Profile on Dr. Pawel Kalinski of Roswell Park Comprehensive Cancer Center who co-leads a clinical study to determine if a combination of $AIM's #ampligen and interferon-alfa-2b can treat #cancer patients with #covid19: ampoleagle.com/local-physician-developing-treatment-for-c… #oncology #biotech #pharmaceutical
-
AIM ImmunoTech
@AimImmuno
Article from The Lancet explains importance of developing a long-term strategy to treat #longcovid patients: www.thelancet.com/journals/lancet/article/PIIS0140-6736(2… $AIM recently announced IRB approval to enroll #covid19 #longhaulers in the AMP-511 #mecfs clinical trial of #ampligen: finance.yahoo.com/news/aim-immunotech-announces-irb-appro…
-
AIM ImmunoTech
@AimImmuno
#proactiveinvestors reports #fda Orphan Status Designation gives $AIM 7 years of exclusivity rights after #ampligen reaches market: www.proactiveinvestors.com/companies/news/937093/aim-immu… #pancreaticcancer #biotech #pharmaceutical #medicine #cancer
-
AIM ImmunoTech
@AimImmuno
$AIM News
AIM ImmunoTech
@AimImmuno
#wsj reports on #aim research for #longcovid: www.wsj.com/articles/experimental-drugs-aim-to-treat-long… The company also recently announced IRB approval to enroll #covid19 #longhaulers in the AMP-511 #mecfs clinical trial of #ampligen: finance.yahoo.com/news/aim-immunotech-announces-irb-appro…
-
AIM ImmunoTech
@AimImmuno
#wsj reports on #aim research for #longcovid: www.wsj.com/articles/experimental-drugs-aim-to-treat-long… The company also recently announced IRB approval to enroll #covid19 #longhaulers in the AMP-511 #mecfs clinical trial of #ampligen: finance.yahoo.com/news/aim-immunotech-announces-irb-appro…
-
AIM ImmunoTech
@AimImmuno
#aim ImmunoTech's #ampligen Awarded #fda's #orphandrug Designation Status for the Treatment of #pancreaticcancer. The company issued a formal announcement today: aimimmuno.irpass.com/ViewEmail.asp?b=2265&id=196500&p=218… #medicalnews #pharmaceutical #biotech #cancer #healthcare #biologics
-
AIM ImmunoTech
@AimImmuno
Lancet reports data presented on the long-term consequences of #covid19 on discharged patients warned that complications could persist for at least 6 months. #longcovid is a burgeoning health concern. www.thelancet.com/journals/ebiom/article/PIIS0140-6736(20… #longhaulers #mecfs #medical #biotech #pharmaceutical
-
AIM ImmunoTech
@AimImmuno
#npr's Scott Simon talks to the president of Dysautonomia International about a new diagnosis that could answer why some people still suffer symptoms months after contracting #covid19. www.npr.org/2020/12/05/943453975/new-condition-sheds-ligh… #longcovid #mecfs #pharmaceutical #healthnews #biotech #medical
-
AIM ImmunoTech
@AimImmuno
Health experts urge #longcovid survivors need ongoing medical attention following #covid19 recovery. www.nytimes.com/2020/12/04/health/covid-long-term-symptom… #healthnews #mecfs #biotech #pharmaceutical
-
AIM ImmunoTech
@AimImmuno
$AIM ImmunoTech Inc. today announced developments in its work to develop new treatments or preventive strategies for #covid-19, the disease caused by SARS-CoV-2: www.globenewswire.com/news-release/2020/11/25/2133583/0/e… #mecfs #clinicaltrials #longcovid #longhaulers #pharmaceutical #biotech #stocks #medical
-
AIM ImmunoTech
@AimImmuno
$AIM today provided a business update for the third quarter ended September 30, 2020. #biotech #pharmaceutical #stocknews #covid #longhaulers #longcovid #mecfs aimimmuno.com/press-release/aim-immunotech-provides-third…
-
AIM ImmunoTech
@AimImmuno
$AIM CEO Tom Equels tells @proactive_NA about published data detailing how its drug #ampligen could have a considerable impact on people living with #mecfs when administered in the disease’s early stages: www.youtube.com/watch?v=C8zY1lGqWoo #pharmaceutical #biotech #longcovid #covid19
-
AIM ImmunoTech
@AimImmuno
$AIM announces the publication of statistically significant data detailing how #ampligen could have a positive impact on #mecfs patients when administered early. The company also says early-onset therapy may be key to #covid #longhauler Syndrome: finance.yahoo.com/news/aim-immunotech-announces-plos-one-… #biotech
-
AIM ImmunoTech reposted
BioFlorida
@BioFlorida
We are proud to present the #bioflorida Weaver H. Gaines Entrepreneur of the Year Award to Tom Equels with AIM ImmunoTech Inc. Your contributions are appreciated! @AimImmuno #bf2020
-
AIM ImmunoTech
@AimImmuno
$AIM congratulates CEO Thomas K. Equels who received BioFlorida’s “Entrepreneur of the Year” award. #bioflorida represents more than 6,700 organizations in the #biopharmaceuticals, #medicaltechnology, #healthit and #bioagriculture sectors: aimimmuno.irpass.com/BioFlorida-Names-AIM-ImmunoTech-CEO-…
-
AIM ImmunoTech
@AimImmuno
"At 12, She’s a #covid #longhauler - Although most young people recover quickly, doctors are seeing some children and teens with lingering fatigue and other chronic problems." www.nytimes.com/2020/10/22/well/family/coronavirus-sympto… #mecfs #healthnews
-
AIM ImmunoTech
@AimImmuno
#mecfs patients share advice for #covid #longhaulers: "We and other chronically ill patients braced ourselves for a different threat: Many more people, we were sure, would soon be joining our ranks." www.washingtonpost.com/health/long-haul-covid-patients/20…
-
AIM ImmunoTech
@AimImmuno
$AIM is pleased to participate in the 2020 #bioflorida Conference featuring global experts in #biopharma, #medtech, #healthit, #covid_19, scientific advancements, business, and public policy, as well as showcase Florida's achievements and innovation: biofloridaconference.pathable.co/meetings/virtual/2oT6yfX…
-
AIM ImmunoTech
@AimImmuno
#covid19 survivor Diana Berrent talks to MSNBC about her turn to advocacy to help those dealing with the long-term effects of the #coronavirus. www.msnbc.com/11th-hour/watch/covid-19-survivor-becomes-a… #longcovid #longhaulers #medical #healthcare #mecfs
-
AIM ImmunoTech reposted
Sumathi Reddy
@rddysum
Many long Covid patients have one thing in common: they are doctors themselves. This week’s column. #longcovid #longhauler www.wsj.com/articles/these-doctors-have-long-term-covid-n…
-
AIM ImmunoTech reposted
Sumathi Reddy
@rddysum
Meet the "long-haulers," the young and healthy Covid-19 patients who never got better. I interviewed 24 of them. A Mount Sinai doctor says many may have developed post-viral dysautonomia, a neurological condition. My column: www.wsj.com/articles/three-months-in-these-patients-are-s… via @WSJ
-
AIM ImmunoTech
@AimImmuno
"As a second wave of infections grows, so it follows that the number of #longcovid cases is bound to increase. Although this clearly has implications for public health and the economy, it has been almost nowhere in the broader policy debate." www.bloomberg.com/opinion/articles/2020-10-15/covid-19-hi… #covid19
-
AIM ImmunoTech
@AimImmuno
Lasting #covid symptoms may not be down to a single syndrome but several different ones: www.theguardian.com/world/2020/oct/15/long-covid-what-we-… #longcovid #longhaulers #mecfs
-
AIM ImmunoTech reposted
#MEAction Network
@MEActNet
#meaction volunteers and staff just met with the CDC! There is much to report, but now we will rest. We prepped so hard to make this meeting as productive as possible and it paid off! The meeting was productive, with more follow up engagement to come. #cdc #mecfs #covid19 💪✌️
-
AIM ImmunoTech reposted
Proactive USA
@proactive_NA
$AIM AIM ImmunoTech is developing immuno-therapeutics to treat multiple types of cancers and fighting coronavirus too www.proactiveinvestors.com/companies/news/931340/aim-immu… via @proactive_NA @AimImmuno #aim
-
AIM ImmunoTech
@AimImmuno
1 in 10 people who had #covid19 reported long-term symptoms in a new study and while they recover at home many are still unwell in need of help. @GMA has more on these "long-haulers:" www.goodmorningamerica.com/wellness/story/newlywed-mom-co… #longcovid #mecfs #medical #clinicaltrials #pharmaceutical #biotech
-
AIM ImmunoTech reposted
#MEAction Network
@MEActNet
New article in @JAMA_current discussing #longcovid includes link to #mecfs. @mhornig shares experience as researcher, physician, & #longhauler. Hornig designed prospective studies w/ @PlzSolveCFS & says we have "unique scientific window" to investigate.
jamanetwork.com/journals/jama/fullarticle/2771111 -
AIM ImmunoTech
@AimImmuno
$AIM Announces #irb Approval to Enroll #covid_19 #longhaulers in the AMP-511 #mecfs #eap #clinicaltrial of #ampligen: aimimmuno.irpass.com/AIM-ImmunoTech-Announces-IRB-Approva… #longcovid #biotech #pharmaceutical #medical #cancer
-
AIM ImmunoTech
@AimImmuno
BBC reports a woman being treated for chronic fatigue after having presumed Covid-19 has called for urgent research into the impact of the virus. www.bbc.com/news/uk-england-cambridgeshire-54323934 #covid19news #biotechnology #medical #healthcare #pharmaceutical #mecfs
-
AIM ImmunoTech
@AimImmuno
$AIM ImmunoTech Inc. today announced receipt of statistically significant positive #pancreatic #cancer survival results from a multi-year Early Access Program (EAP) conducted at Erasmus University Medical Center in the Netherlands. More details: aimimmuno.irpass.com/AIM-ImmunoTech-Receives-Statisticall… #ampligen
-
AIM ImmunoTech
@AimImmuno
$AIM today announced recruitment began in Roswell Park Comprehensive Cancer Center's Phase 1/2a clinical study of the effectiveness of #ampligen in combination with interferon alpha-2b in treating #cancer patients with mild or moderate #covid-19 infection: bit.ly/33wxRH
-
AIM ImmunoTech
@AimImmuno
$AIM will be presenting at #hcwco Annual Global #investment Conference, virtually on September 14, 2020. To register and view the presentation, please visit: wsw.com/webcast/hcw7/register.aspx?conf=hcw7&page=aim&url… #ampligen #mecfs #cancer #longcovid #covid_19 #clinicaltrials #biotech #pharmaceutical
-
AIM ImmunoTech
@AimImmuno
$AIM CEO Thomas K. Equels to participate in Proactive's One2One Virtual Forum – “Defeating Covid-19 - Hidden Breakthroughs Webinar” on September 10 at 1:00 p.m. Register here for more information: zoom.us/webinar/register/8215990551540/WN_YFe8n6dQSm6mpgG… #covid19 #biotechnology #pharmaceuticals
-
AIM ImmunoTech
@AimImmuno
$AIM announces an in vitro model for testing #ampligen at Utah State University shows it decreased SARS-CoV-2 infectious viral yields by 90% and supports AIM's goal of developing an intranasal prophylactic approach to prevent #covid19 aimimmuno.irpass.com/AIM-ImmunoTech-Inc-Decreases-SARS-Co… #biotech
-
AIM ImmunoTech
@AimImmuno
$AIM today announced that it will be presenting at The LD 500 Investor conference being held virtually on September 1-4, 2020: aimimmuno.irpass.com/AIM-ImmunoTech-to-Present-at-The-LD-…
-
AIM ImmunoTech
@AimImmuno
$AIM provides 2020 second quarter update. “…we believe we are extremely well positioned to execute on our strategy going forward, which, in turn, we expect will drive significant value for stockholders," said CEO Thomas K. Equels: aimimmuno.irpass.com/AIM-ImmunoTech-Provides-Second-Quart…
-
AIM ImmunoTech
@AimImmuno
$AIM CEO Thomas K. Equels provided the latest updates on the company’s strategic objectives and its progress with #ampligen #clinicaltrials to treat #mecfs and #covid19 during the SNN Network Virtual Conference on Aug 3, 2020. Watch the presentation here: www.youtube.com/watch?v=hm_uKUM7PfQ
-
AIM ImmunoTech
@AimImmuno
Medical experts believe that some patients who recover from #covid19 can develop a long-term illness known as chronic fatigue syndrome #mecfs, according to a June 2020 letter published in the peer-reviewed journal Medical Hypotheses: www.ktvu.com/news/chronic-fatigue-syndrome-may-linger-aft…
-
AIM ImmunoTech
@AimImmuno
Imagine being young and healthy, a nonsmoker with no preexisting health conditions, and then waking up one morning feeling like you were being suffocated by an unseen force: www.menshealth.com/health/a33573786/covid-long-hauler-epi… #longcovid #covid19 #mecfs
-
AIM ImmunoTech reposted
NSU INIM
@NSU_INIM
Join @headachepolicy, @miles4migraine & @PlzSolveCFS in collaboration w/ the Bipartisan Women’s Caucus on Wednesday, August 12th at 2:30 p.m. ET for an online education roundtable, “Women’s Chronic Illness During a Pandemic."
register.gotowebinar.com/register/4015099114368720143 -
AIM ImmunoTech
@AimImmuno
While awareness is growing about #longcovid in adults, much remains unknown about the potential long-term impacts in children who have been battling fatigue, breathlessness, chest pains, diarrhea, and #covidtoes. #mecfs www.cnn.com/2020/08/10/health/children-long-covid-symptom…
-
AIM ImmunoTech
@AimImmuno
A brain imaging study of veterans with Gulf War illness #gwi and patients with chronic fatigue syndrome #mecfs has shown that the two illnesses produce distinctly different, abnormal patterns of brain activity after moderate exercise. www.sciencedaily.com/releases/2020/08/200810103300.htm
-
AIM ImmunoTech
@AimImmuno
Opinion article written by Leslie Pallone, a licensed mental-health counselor, who has been an #mecfs support group facilitator in Central Florida for 23 years. #longcovid #covid19 www.orlandosentinel.com/opinion/guest-commentary/os-op-co…
-
AIM ImmunoTech reposted
Solve ME/CFS Initiative
@PlzSolveCFS
*NEW WEBINAR!* Thurs., August 27th | 10:00am PDT / 1:00pm EDT
Will COVID-19 lead to ME/CFS in some people? Join Dr. Anthony L. Komaroff for a discussion of what we know so far about the connection between COVID-19 and ME/CFS. @HarvardAskDrK
Register here:
register.gotowebinar.com/register/8645135981709622286 -
AIM ImmunoTech reposted
AIM ImmunoTech
@AimImmuno
$AIM CEO Thomas K. Equels will be presenting live during the SNN Network Virtual Investor Conference 2020 on Monday, August 3 at 1:30 PM EST: aimimmuno.irpass.com/AIM-ImmunoTech-to-Present-at-the-SNN… #covid19 #cancer #mecfs #ampligen #pharmaceutical #biotech #stocks
-
AIM ImmunoTech
@AimImmuno
$AIM CEO Thomas K. Equels updates Stock News Now about the company’s efforts in #clinicaltrials to develop potential therapies for #covid-19 patients with Chronic Fatigue Syndrome #mecfs and #cancer. www.youtube.com/watch?v=65A2AvF_ozc #pharmaceutical #longcovid #biotech #ampligen
-
AIM ImmunoTech
@AimImmuno
$AIM
AIM ImmunoTech
@AimImmuno
Investor Place issues opinion article on $AIM’s ambitious #covid19 research: AIM ImmunoTech Seduces with Coronavirus Treatment Potential. Read the full story investorplace.com/2020/07/aim-stock-is-a-covid-19-player-… #cdc #nih #mecfs #cancer #clinicaltrials #biotech #pharmaceutical #stocks
-
AIM ImmunoTech reposted
Solve ME/CFS Initiative
@PlzSolveCFS
COVID-19’s Long-Term Effects Raise the Stakes of the Game. "We now know that many who recover from the initial symptoms of COVID-19 experience serious and long-lasting sequelae, or abnormalities resulting from the illness." #longcovid #longhaulers
humanevents.com/opinion/covid-19s-long-term-effects-raise… -
AIM ImmunoTech
@AimImmuno
$AIM CEO Thomas K. Equels will be presenting live during the SNN Network Virtual Investor Conference 2020 on Monday, August 3 at 1:30 PM EST: aimimmuno.irpass.com/AIM-ImmunoTech-to-Present-at-the-SNN… #covid19 #cancer #mecfs #ampligen #pharmaceutical #biotech #stocks
-
AIM ImmunoTech reposted
Solve ME/CFS Initiative
@PlzSolveCFS
Could COVID-19 Trigger Chronic Disease in Some People? www.the-scientist.com/news-opinion/could-covid-19-trigger…
-
AIM ImmunoTech
@AimImmuno
Investor Place issues opinion article on $AIM’s ambitious #covid19 research: AIM ImmunoTech Seduces with Coronavirus Treatment Potential. Read the full story investorplace.com/2020/07/aim-stock-is-a-covid-19-player-… #cdc #nih #mecfs #cancer #clinicaltrials #biotech #pharmaceutical #stocks
-
AIM ImmunoTech
@AimImmuno
#drfauci warns about post-viral syndrome after #covid19: "This condition is called myalgic encephalomyelitis #me-like illness. ME was previously called #chronicfatiguesyndrome." #mecfs www.healthline.com/health/post-viral-fatigue
-
AIM ImmunoTech
@AimImmuno
$AIM CEO answers questions about Phase 1/2a clinical trial agreement with Roswell Park Cancer Treatment Center to fight #covid19 in #cancer patients; also discusses new agreement in Japan www.proactiveinvestors.com/companies/news/924632/aim-immu… #clinicaltrials #pharmaceutical #biotechnology #mecfs
-
AIM ImmunoTech
@AimImmuno
The #fda authorizes Roswell Park Comprehensive Cancer Center to conduct a study evaluating the safety and efficacy of $AIM's #ampligen plus interferon alfa-2b as a novel immunotherapy combination for the treatment of #covid19 infection in #cancer patients www.healio.com/news/hematology-oncology/20200715/immunoth…
-
AIM ImmunoTech reposted
Solve ME/CFS Initiative
@PlzSolveCFS
Four Years of Advocacy has paid off! We’re Proud to have Authored and Initiated the First Ever Legislation for ME/CFS Research Funding, H.R. 7057, The Understanding COVID-19 Subsets and ME/CFS Act
raskin.house.gov/media/press-releases/raskin-introduces-l…
#solveme #solvemecfs #covid19 #mecfs #meawarenesshour -
AIM ImmunoTech
@AimImmuno
Two #cdc physicians talk about the challenges associated with diagnosing and managing #mecfs. One of the physicians describes the 2015 Institute of Medicine Report on ME/CFS and how it helped him with the symptom identification.
www.youtube.com/watch?v=RFMVtEqJT2Q -
AIM ImmunoTech
@AimImmuno
#mecfs #chronicfatiguesyndrome
NBC News
@NBCNews
Some COVID-19 patients aren't getting better. Major medical centers are trying to figure out how to help. nbcnews.to/3idyoVh
-
AIM ImmunoTech reposted
The Times and Sunday Times
@thetimes
Nina Muirhead saw 13 doctors over ten months before she was diagnosed with a condition she did not believe existed.
Read the full story here: www.thetimes.co.uk/article/chronic-fatigue-syndrome-it-fe… -
AIM ImmunoTech reposted
Robert Saunders (aka McMullen)
@RobertHMcMullen
No fewer than 3 articles about ME in Wednesday’s Times, including a leading article.
1. www.thetimes.co.uk/edition/news/chronic-fatigue-syndrome-…
2. www.thetimes.co.uk/article/chronic-fatigue-syndrome-we-wo…
3. www.thetimes.co.uk/article/the-times-view-on-taking-myalg…
Thanks to @TimesONeill and others for all the positive coverage of ME in The Times this week. -
AIM ImmunoTech
@AimImmuno
$AIM CEO Thomas K. Equels updates #ceoroadshow on the progress of #ampligen clinical trials and the prospect that it could be a therapy for #covid19 patients with #cancer or #chronicfatiguesyndrome #mecfs www.youtube.com/watch?v=brBnYsMyzBw&t=193s
-
AIM ImmunoTech
@AimImmuno
$AIM CEO Thomas K. Equels speaks with @proactive_NA about commercial approval of #ampligen in Argentina as a therapy for the treatment of #mecfs and studies showing it could be effective in treating #covid__19 induced #mecfs. www.proactiveinvestors.com/companies/news/922460/aim-immu… #covid #pharmaceutical
-
AIM ImmunoTech
@AimImmuno
-
AIM ImmunoTech
@AimImmuno
$AIM ImmunoTech provided an update on the commercial launch of #ampligen® for the treatment of #mecfs in Argentina: aimimmuno.irpass.com/AIM-ImmunoTech-Provides-Update-on-Co… #pharmaceuticals #biotech #aimimmunotech #covid19 #chronicfatiguesyndrome #argentina
-
AIM ImmunoTech
@AimImmuno
Ocala Style magazine features $AIM #ceo Thomas K. Equels in the June 2020 issue: www.ocalastyle.com/sense-of-destiny/ #biotech #pharmaceutical
-
AIM ImmunoTech
@AimImmuno
“Given the large amount of clinical data already supporting #ampligen in #mecfs we look forward to the chance to investigate how Ampligen may be of value should there be a surge of #covid19 induced CFS-like cases worldwide.” -Thomas K. Equels, CEO aimimmuno.irpass.com/AIM-ImmunoTech-Files-Provisional-Pat… $AIM
AIM ImmunoTech
@AimImmuno
#chronicfatiguesyndrome #aimimmunotech #biotech #pharmaceutical
-
AIM ImmunoTech
@AimImmuno
Washington Post: Researchers Warn COVID-19 Could Cause Debilitating Long-term Illness in Some Patients www.washingtonpost.com/health/could-covid-19-cause-long-t… @brianvastag @BethMazur #mecfs #pwme #covid19 #missingmillions
-
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech and Shenzhen Smoore Technology Announce an Agreement to Research Utilizing an Innovative Smoore Inhalation Delivery Device and Ampligen (rintatolimod) as a Potential, Easy-To-Use Treatment Approach for the SARS-CoV-2 Pandemic aimimmuno.irpass.com/AIM-ImmunoTech-and-Shenzhen-Smoore-T…
-
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces the National Cancer Institute's Award of $14.54M to Study Ampligen as Part of Five Roswell Park-led Chemokine Modulation Clinical Trials in Melanoma, Colorectal and Ovarian Cancers aimimmuno.irpass.com/AIM-ImmunoTech-Announces-the-Nationa…
-
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Reports 2019 Year-end Financial Results aimimmuno.irpass.com/AIM-ImmunoTech-Reports-2019-Year-end…
-
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Further Efforts to Establish Clinical Trials Assessing Ampligen as a Potential Protective and Early-Onset Treatment for the Current COVID-19 Pandemic aimimmuno.irpass.com/AIM-ImmunoTech-Announces-Further-Eff…
-
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech's Drug Ampligen to Be Tested by Japan's National Institute of Infectious Diseases as a Potential Treatment for the New SARS Coronavirus (SARS-CoV-2) Responsible for the New Human Infectious Disease COVID-19 aimimmuno.irpass.com/AIM-ImmunoTechs-Drug-Ampligen-to-Be-…
-
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Joins with ChinaGoAbroad for an Ampligen China Entry Against COVID-19, the New SARS-like Coronavirus Disease Epidemic aimimmuno.irpass.com/AIM-ImmunoTech-Joins-with-ChinaGoAbr…
-
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Issues Stockholder Update on the Potential Role of Ampligen for Use Against the Wuhan Coronavirus Epidemic aimimmuno.irpass.com/AIM-ImmunoTech-Issues-Stockholder-Up…
-
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech's CEO to Appear Live Today on FOX Business Network's The Claman Countdown and Cheddar's Opening Bell to Discuss the Potential Role of Ampligen for Use Against the Wuhan 2019 Novel Coronavirus aimimmuno.irpass.com/AIM-ImmunoTechs-CEO-to-Appear-Live-T…
-
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Files Three Provisional Patent Applications Surrounding Ampligen(R) for Use Against the SARS-like Wuhan 2019 Novel Coronavirus aimimmuno.irpass.com/AIM-ImmunoTech-Files-Three-Provision…
-
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Announces Completion of Third-Party Clinical Trial Using Ampligen in Combination with Other Therapies as Adjuvant Treatment of Peritoneal Surface Malignancies aimimmuno.irpass.com/AIM-ImmunoTech-Announces-Completion-…
-
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech to Present at the Investor Summit in Philadelphia aimimmuno.irpass.com/AIM-ImmunoTech-to-Present-at-the-Inv…
-
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Issues Stockholder Update and Details Its Expectations for 2020 aimimmuno.irpass.com/AIM-ImmunoTech-Issues-Stockholder-Up…
-
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Provides Business Update for the Third Quarter of 2019 aimimmuno.irpass.com/CORRECTION-AIM-ImmunoTech-Provides-B…
-
AIM ImmunoTech
@AimImmuno
-
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference aimimmuno.irpass.com/AIM-ImmunoTech-to-Present-at-the-Daw…
-
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Provides Comprehensive Clinical Trials Update With Major Inflection Points Identified aimimmuno.irpass.com/AIM-ImmunoTech-Provides-Comprehensiv…
-
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech, Inc. Announces Pricing of $8 Million Public Offering aimimmuno.irpass.com/AIM-ImmunoTech-Inc-Announces-Pricing…
-
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Inc. Announces a Second DoD Award, This One of $8.3 Million, to Fund Phase 2 Clinical Trial to Study Ampligen as Part of a New Treatment for Brain-Metastatic Breast Cancer at the Moffitt Cancer Center aimimmuno.irpass.com/AIM-ImmunoTech-Inc-Announces-a-Secon…
-
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech's Ampligen Receives Clearance from FDA for Exportation to Argentina for the Treatment of Severe Chronic Fatigue Syndrome aimimmuno.irpass.com/AIM-ImmunoTechs-Ampligen-Receives-Cl…
-
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Inc. Announces the U.S. Department of Defense's Award of $6.42M to Roswell Park Comprehensive Cancer Center to Study Ampligen as Part of a New Treatment of Brain-Metastatic Breast Cancer aimimmuno.irpass.com/AIM-ImmunoTech-Inc-Announces-the-US-…
-
AIM ImmunoTech
@AimImmuno
AIM ImmunoTech Names Ellen Lintal as New Chief Financial Officer aimimmuno.irpass.com/AIM-ImmunoTech-Names-Ellen-Lintal-as…
-
AIM ImmunoTech
@AimImmuno
Hemispherx Biopharma is now AIM ImmunoTech. Follow us and check in frequently to get the latest news.




















































































































































































































































































































































































































































































































































































































































































